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Abstract 
Human Class I phosphatidylinositol transfer proteins (PITPs) exists in two forms: PITPα 
and PITPβ.  PITPs are believed to be lipid transfer proteins based on their capacity to transfer 
either phosphatidylinositol (PI) or phosphatidylcholine (PC) between membrane compartments 
in vitro.  In Drosophila, the PITP domain is found to be part of a multi-domain protein named 
retinal degeneration B (RdgBα).  The PITP domain of RdgBα shares 40 % sequence identity 
with PITPα and has been shown to possess PI and PC binding and transfer activity.   
The detailed molecular mechanism of ligand transfer by the human PITPs and the 
Drosophila PITP domain remains to be fully established.  Here, we investigated the membrane 
interactions of these proteins using dual polarization interferometry (DPI).  DPI is a technique 
that measures protein binding affinity to a flat immobilized lipid bilayer.  In addition, we also 
measured how quickly these proteins transfer their ligands to lipid vesicles using a fluorescence 
resonance energy transfer (FRET)-based assay.   
DPI investigations suggest that PITPβ had a two-fold higher affinity for membranes 
compared to PITPα.  This was reflected by a four-fold faster ligand transfer rate for PITPβ in 
comparison to PITPα as determined by the FRET assay.  Interestingly, DPI analysis also 
demonstrated that PI-bound human PITPs have lower membrane affinity compared to PC-bound 
PITPs.   
In addition, the FRET studies demonstrated the significance of membrane curvature in 
the ligand transfer rate of PITPs. The ligand transfer rate was higher when the accepting vesicles 
were highly curved.  Furthermore, when the accepting vesicles contained phosphatidic acid (PA) 
which have smaller head groups, the transfer rate increased.  In contrast, when the accepting 
vesicles contained phosphoinositides which have larger head groups, the transfer rate was 
diminished.  However, PI, the favorite ligand of PITPs, or the presence of anionic lipids did not 
appear to influence the ligand transfer rate of PITPs.   
Both DPI and FRET examinations revealed that the PITP domain of RdgBα was able to 
bind to membranes.  However, the RdgBα PITP domain appears to be a poor binder and 
transporter of PC.    
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1. INTRODUCTION 
1.1 Phospholipids: Essential Building Blocks of Biomembranes 
Phospholipids constitute one of the main lipid structural elements of cellular 
membranes.  Biological membranes are crucial as they function as cellular boundaries 
separating the ordered living cell from its surrounding chaotic environment.  
Glycerophospholipids are a group of lipids whose backbone is based on a three carbon 
glycerol molecule.  Two fatty acid chains are attached at position sn-1 and sn-2 – Figure 
1 [1].  The fatty acid chain at position sn-1 is generally saturated and composed of 16 or 
18 carbon atoms.   In contrast, the fatty acid chain at position sn-2 is usually longer and 
unsaturated containing one or more cis-double bonds [2].    When position sn-3 carries a 
phosphate group it is called phosphatidic acid (PA).  This phosphate group can be 
esterified to different head-groups giving rise to several types of phospholipids including 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS) and 
phosphatidylinositol (PI) – Figure 1 [1].   Each phospholipid group can encompass many 
more species based on the length and degree of unsaturation in the fatty acid chains [3]. 
Phospholipids make up the bulk of membranes in eukaryotic cells (60-65 mol% of 
the total lipid fraction) [2, 4].  Nearly 50 % of this fraction is attributed to PC. The reason 
behind this phospholipid distribution in membranes is because PC has the capacity to 
self-assemble spontaneously into a planar bilayer due to its inherent cylindrical shape.  
Consequently, this characteristic of PC is essential in providing a stable bilayer 
membrane structure [3, 4].  Moreover, most PC molecules possess one cis-unsaturated 
acyl chain which is important for membrane fluidity.  It is important to note that 
biological membranes are not comprised solely of phospholipids, but also contain many 
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more lipid species that serve different functions ranging from cell signaling to membrane 
trafficking [1].    
 
Figure 1:  Phospholipid structure   
The phospholipid head-groups are shown in the box.  Both the glycerol backbone and 
inositol head-group of PI are numbered. 
 
1.2 Phosphatidylinositol: Precursor for Phosphoinositides 
PI is unique in that it acts not only as a structural lipid but also as a precursor for 
signaling molecules [5].  In comparison to PC, PI only accounts for approximately 10 - 
20 mol% of the total lipid fraction in mammals [6].  The inositol head-group of PI can be 
reversibly phosphorylated by lipid kinases at positions -3, -4 and -5 giving rise to a group 
of signaling molecules known as phosphoinositides.  To date there are seven known 
phosphoinositides in mammalian cells – Table 1 [6].  Although phosphoinositides make 
up about 1 mol% of the total cellular lipid content they play important roles in many 
biological processes.  These biological activities include, but are not limited to, lipid 
metabolism and distribution, signal transduction cascades and vesicle trafficking [6-7].   
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The distribution of phosphoinositides varies significantly within the cell and is 
dependent on the location of phosphoinositide modifying-enzymes.  These enzymes 
include lipid kinases and phosphatases that attach and remove phosphate groups 
respectively.  Consequently, phosphoinositides are positioned at distinct intracellular 
membranes and act as organelle markers – Table 1 [8].   
Table 1: Phosphoinositides – diversity and location. 
A summary is shown here of the seven known phosphoinositides and their dominant 
membrane location in mammalian cells [7, 9].   
 
Phosphoinositide Abbreviation Membrane Location 
Phosphatidylinositol-3-phosphate PI(3)P Early endosomes 
Phosphatidylinositol-4-phosphate PI(4)P Golgi complex 
Phosphatidylinositol-5-phosphate PI(5)P Nucleus 
Phosphatidylinositol-3,4-
phosphate 
PI(3,4)P2 Early endosomes, plasma 
membrane 
Phosphatidylinositol-3,5-
phosphate 
PI(3,5)P2 Late endosomes, lysosomes 
Phosphatidylinositol-4,5-
phosphate 
PI(4,5)P2 Plasma membrane, nucleus 
Phosphatidylinositol-3,4,5-
phosphate 
PI(3,4,5)P3 Plasma membrane 
 
 
 Amongst the seven known phosphoinositides, both PI(4,5)P2 and PI(3,4,5)P3 are 
the most well studied phosphoinositides.  Both PI(4,5)P2 and PI(3,4,5)P3 are located in 
the plasma membrane [7, 9].  PI(4,5)P2 is synthesized in two steps: (i) the conversion of 
PI to PI4P by a PI 4-kinase and (ii) the conversion of PI4P to PI(4,5)P2 by a PI(4)P 5-
kinase [9].  PI(4,5)P2 holds a key role in phosphoinositide signaling as it not only acts as 
a signaling molecule but also acts as a precursor for other signaling molecules.  As a 
signaling molecule, PI(4,5)P2 acts to recruit effector proteins that are involved in various 
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cellular processes which include endocytosis, exocytosis, cell migration and endosomal 
trafficking [10].  PI(4,5)P2 can be dephosphorylated by at 5′-position by 5-phosphatases 
to generate PI(4)P [6].   
 PI(4,5)P2 can be further converted to PI(3,4,5)P3 by PI 3-kinase.  This conversion 
occurs in response to extracellular stimuli such as epidermal growth factor (EGF).  
PI(3,4,5)P3 then recruits effector proteins that regulate several cellular functions 
including cell growth and survival, cell cycle progression and intracellular vesicle 
trafficking [11].  PI(3,4,5)P3 can be converted back to PI(4,5)P2 through 
dephosphorylation at the 3′-position by PTEN (phosphatase and tensin homolog), a tumor 
suppressor protein [11].   
 In addition, PI(4,5)P2 can be cleaved by phospholipases C (PLC) to generate two 
important lipid second messengers: diacylglycerol (DAG) and inositol 1,4,5-triphosphate.  
While inositol triphosphate releases Ca
2+
 stores, DAG activates protein kinase C (PKC) 
which in turn activates other proteins within the cell by phosphorylation [9].   
1.3 Lipid Trafficking Mechanisms 
The endoplasmic reticulum (ER) is the main site for the synthesis of most, if not 
all, lipids.  Since these lipids are not confined to the ER, newly synthesized lipids are 
delivered to other membrane compartments where they are required [6, 12].  In the case 
of PI, PI transport is required for PI phosphorylation to occur at non-ER membrane 
compartments.  Delivery of PI from the ER to other membrane locations is mainly 
achieved by means of vesicular transport and/or lipid carrier proteins [13].   
To date several lipid trafficking mechanisms have been identified which can be 
broadly categorized under vesicular or non-vesicular lipid transport.  Vesicular trafficking 
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entails the budding of a lipid vesicle from a donor membrane followed by the fusion of 
that vesicle with an acceptor membrane.  In this manner, large amounts of lipids are 
transported from one organelle to another.  This type of transport is observed in the 
endocytic and exocytic pathways [14].  Non-vesicular trafficking, on the other hand, 
includes several processes that can be further classified into intramembrane and 
intermembrane trafficking.   
Intramembrane non-vesicular lipid transport can occur through the process of 
lateral diffusion and transbilayer flip-flop [14].  Lateral diffusion occurs when a lipid 
molecule moves in the lateral plane of the membrane bilayer.  Typical lateral diffusion 
rates are in the order of 10
-9
 to 10
-8
 cm
2
/sec [15].  This type of transport is usually 
confined within the same membrane compartment.   
In contrast, transbilayer flip-flop takes place when a lipid molecule moves from 
one leaflet to another across the lipid bilayer.  Flip-flop can occur spontaneously or with 
the assistance of proteins [14].  In vitro studies revealed that the rate of spontaneous flip-
flop is dependent on the nature of the lipid head-groups.  Lipids, such as DAG and 
cholesterol, which lack or possess small polar head group possess a faster flip-flop rate 
with half-times, t1/2, ranging between seconds to minutes.  On the contrary, lipids that 
carry a polar head-group such as PC possess a slower flip-flop rate with t1/2 ranging 
between hours to days [1].  Taking this into consideration, spontaneous flip-flop alone is 
insufficient to support the lipid distribution observed in biological membranes; hence, 
protein-mediated flip-flop is essential here, which helps to accelerate the slow 
transbilayer movement of lipids [16]. 
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Intermembrane non-vesicular transport involves monomeric lipid exchange or 
desorption which can occur spontaneously or by means of lipid transfer proteins (LTPs) 
[14].  Spontaneous lipid desorption takes place when a single lipid molecule moves from 
the outer leaflet of a donor membrane into the cytoplasm and inserts itself into the outer 
leaflet of an acceptor membrane [1].  The rate of spontaneous lipid exchange is dependent 
on the lipid’s aqueous phase solubility.  For example, lyso-phosphatidylcholine, which 
has a single acyl chain, undergoes spontaneous transfer more rapidly (t1/2 of minutes) than 
phosphatidylcholine, which possess two acyl chains (t1/2 of days) [1, 14].  In general, 
spontaneous lipid desorption is a slow process and requires a close proximity between 
both the donor and acceptor membranes.  Despite this limitation, spontaneous lipid 
exchange is essential for organelles such as mitochondria that are not part of the vesicular 
pathway and lack the machinery to produce their own full repertoire of lipids [1].  
Spontaneous lipid exchange alone is insufficient to support a significant transport of 
lipids, particularly of those found in the non-vesicular pathway [14].  The discovery of 
LTPs has led to the belief that these proteins may play a role in accelerating spontaneous 
lipid desorption [14].  Studies have shown that when vesicular trafficking was blocked by 
means of drugs such as brefeldin A, which inhibits coat protein complex I (COPI)-
mediated transport vesicles, a significant amount of intermembrane lipid transport was 
still observed [17].  In this study, the transport of PE from its sites of synthesis to the cell 
surface was examined in rat hepatocytes.  PE is synthesized in the endoplasmic reticulum 
from cytidine diphosphate (CDP)-ethanolamine and in the mitochondria by 
decarboxylation of PS [18].  Rat hepatocytes were first incubated with radiolabeled 
ethanolamine or serine, which are precursors of PE.  The amount of newly synthesized 
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PE incorporated into the cell surface was determined by reaction with trinitrobenzene 
sulfonate (TNBS) to produce N-trinitrophenyl-PE.  TNBS only reacts with PE when it is 
located on the outer surface of cells [18].  The amount of PE incorporated into the cell 
surface did not change in the absence or presence of brefeldin A, which disrupts protein 
trafficking via the Golgi [18].  This observation implies that lipid transport is not solely 
dependent on vesicular trafficking.  Moreover, since spontaneous lipid exchange is a slow 
process, this type of transfer mechanism alone is insufficient to support the observed lipid 
transport [19].  Therefore, this observation further supports the involvement of proteins in 
lipid trafficking. 
 
Figure 2: Types of non-vesicular lipid transfer mechanisms. 
Shown here is an illustration of the intermembrane and intramembrane non-vesicular 
lipid transport mechanisms.  Intermembrane transport includes spontaneous and LTP-
mediated transfer while intramembrane transport comprises both flip-flop and lateral 
diffusion.  (Reproduced with permission from reference 14) 
 
LTPs were first discovered as soluble factors that accelerate lipid exchange 
between membranes in vitro [14].  Since then, many LTPs have been identified and they 
can be grouped according to the type of lipid they transfer: phospholipid transfer proteins, 
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fatty acid transfer proteins, sterol transfer proteins and sphingolipid transfer proteins.  
Generally, LTPs transfers a single lipid molecule at a time and are specific for one type of 
lipid molecule.  However, some LTPs can bind more than one lipid molecule [14].  A 
summary of the non-vesicular transport mechanisms is shown in Figure 2.   
1.4 The Phosphatidylinositol Transfer Protein Family 
1.4.1 Introduction 
It is understood that PI transport is essential for supplying PI to other non-ER 
membrane compartments for the generation of phosphoinositides and for structural 
purposes.  As mentioned previously, PI transfer is accomplished by means of vesicular 
transport and/or carrier proteins.  Carrier proteins that have the capacity to bind and 
transfer PI in vitro in an energy-independent manner have been identified.  This group of 
transfer proteins is collectively known as the phosphatidylinositol transfer proteins 
(PITPs).  The unique feature of these proteins is their capacity to not only bind PI but PC 
also.  However, PITPs have a 16-fold higher affinity for PI compared to PC and 
accommodate only one lipid molecule at a time [20]. 
PITPα, the first mammalian PITP discovered, was purified in 1974 from brain 
cytosol [21].  The purified protein was found to exist as two species that differ only by 
charge.  This charge variance was attributed to the type of ligand that was bound to 
PITPα.  The more negatively charged species was found to contain PI while the less 
negatively charged form bound PC [22].  Since the discovery of PITPα, the number of 
PITP proteins has expanded.  Currently, there are at least five PITP proteins in humans 
that can be grouped as Class I and II PITPs [22].   
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Class I PITPs consists of PITPα and PITPβ, which share 77 % sequence identity 
and 94% sequence similarity [23].  Both PITPα (270 amino acids) and PITPβ (270 amino 
acids for sp1 and 271 amino acids for sp2) are soluble proteins with a molecular weight 
of ~32 kDa containing a single lipid-binding domain (the PITP domain).  The gene 
locations for both proteins are on chromosome 17q13 and 22q12 respectively [24].  
PITPβ can be alternatively spliced to produce two splice forms, sp1 and sp2, which differ 
by 17 amino acids at the C-terminus [24].  In addition, studies revealed that PITPβ is 
capable of transferring sphingomyelin in addition to both PC and PI [25].  While PITPα is 
mainly localized in the nucleus and cytoplasm, PITPβ is associated with the endoplasmic 
reticulum and Golgi apparatus [25].  PITPα is highly expressed in the brain while PITPβ 
is found mainly in liver cells [23].  Their different localization and expression imply that 
both proteins perform different functions.   
PITPα is believed to play a role in neuronal, liver, and intestinal function [26].  
When PITPα expression is reduced, as seen in the mouse vibrator phenotype, 
neurodegeneration in the brain and spinal cord is observed.  Moreover, vibrator mice die 
thirty days after birth [27].  The vibrator phenotype is a result of a mutation that involves 
a retroposon insertion in an intron of the PITPα gene, PITPNA.  Consequently, both 
mRNA levels and protein expression are reduced [27].  However, mice that completely 
lack PITPα not only exhibit spinocerebellar disease but also possess lower body fat and 
abnormal accumulation of lipids in both enterocytes and hepatocytes.  In addition, these 
mice are hypoglycemic and are prone to neonatal death.  Both the intestinal disorder and 
hypoglycemia can be rectified by re-expression of PITPα but not the neonatal lethality 
[26].   
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 PITPβ, on the other hand, was observed to be required for the Golgi-endoplasmic 
reticulum retrograde traffic and the maintenance of PI(4)P levels in Golgi membranes 
[27].  PITPβ was deemed to play an essential role in mammals compared to PITPα.  
Deletion of the PITPβ gene in murine cells was shown to be embryonically lethal [28].  
In PITPβ knockdown cells, defects in the retrograde transport between the Golgi complex 
and ER were observed.   The retrograde transport can be restored by the expression of 
wild type PITPβ [23].  The PITPβ knockdown cells also displayed a decrease in PI(4)P 
levels suggesting that PITPβ may play a role in maintaining the levels of this lipid in the 
Golgi.  The details of this mechanism are still not fully established.  In fact, the cellular 
functions of both PITPα and PITPβ remain unclear.  The close association of PITPs with 
signaling molecules, particularly the phosphoinositides, poses a challenge in deciphering 
their actual cellular function.  This closely linked relationship between the PITPs and 
phosphoinositides makes it difficult to differentiate whether an outcome is the result of a 
PITP malfunction or a defect in phosphoinositide signaling.   
 The Class II PITPs encompasses both single domain (RdgBβ) and multi-domain 
(RdgBαI and RdgBαII) proteins.  The PITP domain of these proteins share approximately 
40 % sequence identity with PITPα.  Similarly to PITPβ, RdgBβ undergoes alternative 
splicing to generate two variants, sp1 and sp2, that vary at the C-terminus [27].  The 
RdgBα proteins are large proteins containing the PITP domain at the N-terminus.  These 
proteins also possess a FFAT motif (diphenylalanine, FF, in an Acidic Tract), a DDHD 
heavy-metal binding domain and a LNS2 domain (Lipin/Ned1/Smp2) [24].  The FFAT 
motif acts as a targeting signal to the endoplasmic reticulum via interaction with VAP 
proteins (VAP stands for VAMP-associated-protein; VAMP stands for vesicle-associated 
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membrane protein) [29].  The DDHD domain contains four non-contiguous conserved 
amino acid residues: three aspartates and a histidine that form a metal binding site.  
However, the function of the LNS2 domain remains to be defined [24].  Given that the 
multi-domain RdgBα proteins possess the capacity to target membranes with the aid of 
targeting signals, the following question arises for the single domain PITPs: how do these 
proteins identify their target membranes for transferring PI or PC?  The focus of this 
thesis will be addressing this question for the Class I PITPs. 
 
Figure 3: The human PITP family and their domain structure. 
The human PITP family consists of five members grouped into two classes – Class I and 
II.  Each member possesses the PITP domain (blue) at the N-terminus.  Class I PITPs 
consists of PITPα and PITPβ which are single domain proteins.  Class II PITPs are made 
up of both single (RdgBβ) and multi-domain proteins (RdgBαI and RdgBαII).  Both 
PITPβ and RdgBβ undergo alternative splicing to produce two variants that differ at the 
C-terminus.  The other domains present are colour coded: red (FFAT), orange (DDHD) 
and green (LNS2).  The number of amino acids and percent sequence identity of the PITP 
domain for each member is shown as well.  (Adapted with permission from reference 27) 
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1.4.2 The PITP Domain Structure 
The crystal structures of PITPα in the ligand-bound (either with PC or PI) and the 
apo form have been solved by x-ray diffraction [30-32].  Rat PITPα was used to generate 
the PC-loaded structure (PDB code: 1T27) while human PITPα was used to produce the 
PI-loaded form (PDB code: 1UW5).  Human PITPα shares an almost identical sequence 
to rat PITPα with the exception of a single deletion at position 52 and conservative 
changes I140V and K219R [30].  For convenience and consistency purposes, the rat 
numbering system for PITPα will be used throughout this thesis.  Comparison between 
human PITPα-PI and rat PITPα-PC reveal no significant difference in the overall protein 
conformation with a root mean square deviation (rmsd) of 0.914 Å
2
 – Figure 4 [33].  The 
crystal structure of rat PITPβ bound to PC has also been resolved.  When compared to 
human PITPα-PC, no substantial change was observed to the overall protein fold; the 
rmsd calculated was 0.934 Å
2
 - Figure 4 [25, 33].   
 
 
Figure 4: Superposition of rat and human PITPs 
The green trace represents rat PITPα, the golden trace is human PITPα and the blue trace 
signifies rat PITPβ.  (Reproduced with permission from reference 33) 
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 The ligand-bound conformations of both PITPα and PITPβ, regardless of species 
origin, reveal the presence of a single phospholipid binding site.  This lipid binding cavity 
is a characteristic feature of LTPs and accommodates a single lipid molecule.  In PITPs, 
this binding site is made up of eight β-strands flanked by two long α-helices, helices A 
(residues 14-33) and F (residues 206-236) [34].  The binding site is closed by a “lid” that 
is made up of a C-terminal α-helix (G helix, residues 240-261) and an 11 amino acid 
extension.  The “lid” also contains another small helix (helix B, residues 70-75) which is 
referred to as the “lipid exchange loop” [32].  In addition to the hydrophobic pocket, there 
are three α-helices that make up the regulatory loop – Figure 5.  This loop region 
contains a serine residue, S166, which is conserved in almost all PITPs.   S166 is located 
in a consensus sequence for phosphorylation by protein kinase C [34].  The specific role 
of PITP’s regulatory loop remains to be established. 
 Comparison between the ligand-bound and apo state of PITP reveal that the G-
helix adopts a different conformation in the apo form – Figure 5.  In the ligand-free state, 
the G-helix is dislodged by 20 ° exposing hydrophobic residues that reside in the lipid-
binding pocket.  In addition, the lipid exchange loop is swung out by 90 ° contributing to 
the opening of the hydrophobic cavity [32].   It is unlikely that PITP will adopt this 
conformation in solution as exposing so much of the hydrophobic surface would be 
thermodynamically unfavorable.  Studies revealed that the C-terminus of PITPα is subject 
to trypsin digestion only in the presence of lipid vesicles.  This observation implies that 
PITPα adopts a tightly closed conformation in an aqueous environment (while 
transporting lipids) but adopts an open conformation upon interaction with vesicles [35].  
Therefore, it is proposed that the open conformation is likely to occur only when PITP is 
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bound to membranes.  The opening of the cavity either allows the protein-bound 
phospholipid to access entry into the membrane’s interface or phospholipids from the 
membrane to access the hydrophobic cavity for transport purposes [27].  The open 
conformation thus provides a structural basis for the extraction of PC or PI by PITPs [32]. 
Observations of the ligand-bound structure reveal that the phospholipid molecule 
is buried within the protein.  The lipid-binding site is composed of a polar binding pocket 
and two hydrophobic channels [27].  The polar binding pocket, located at the opposite 
end of the cavity’s opening, recognizes the phospholipid head-groups.  The fatty acid 
chains are located in the two hydrophobic channels which projects toward the opening of 
the cavity [27].   This closed conformation of PITP provides a means by which PITPs 
transfers its ligands through aqueous environments.   
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Figure 5: Closed (A) and open (B) conformation of PITPα. 
For both structures the beta sheets are in yellow, alpha helices are in red and loops are in 
green.  The lipid binding core is made up of the eight β-strands and α-helices A and F.  
The ‘lid’ region is made up of helix G and an 11 amino acid extension.  The lipid 
exchange loop also make up part of the ‘lid’.  Three helices form the regulatory loop.  PC 
is shown in blue and two tryptophan residues (W203/W204) involved in membrane 
binding are highlighted in purple.  Structures were generated by PYMOL software using 
Protein Data Bank (PDB) files 1T27 and 1KCM.   
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1.4.3 PITP Membrane Docking 
In order for PITP to bind to membranes and facilitate lipid exchange, a 
mechanism is required to explain the conformational change involved in this process.  
Two tryptophan residues at positions 203 and 204 have been identified to play a role in 
the membrane docking process of PITP – violet residues in Figure 5A.  Both tryptophan 
residues are exposed on the loop between β-strand 8 (residues 191-201) and α-helix F 
(residues 206-236) instead of being buried in the protein core [30].  Mutation of both 
W203 and W204 to alanine results in a loss of membrane docking and lipid transfer [30, 
36].  This evidence was observed in two different in vitro assays.  The first assay utilized 
permeabilized HL60 cells as the donor membrane, while the second assay used rat liver 
microsomes.  The acceptor membranes in both assays were synthetic liposomes 
consisting of 98 mol% PC and 2 mol% PI [36-37].  In both assays, the donor membranes 
were labeled with either [
3
H]PI or [
3
H]PC and the amount of radioactivity transferred to 
the acceptor liposomes was quantified to determine transfer activity.  In the presence of 
the W203A/W204A mutant both PI and PC transfer was diminished [30, 36-37].  
However, the W203A/W204A mutant was still able to bind to either PI or PC but 
significantly lower compared to wild type PITPα [30].   
The Orientation of Proteins in Membranes (OPM) database is a web resource 
providing a collection of transmembrane, peripheral and monotopic integral proteins 
whose position in the lipid bilayer has been determined theoretically.  The purpose of the 
OPM is to determine the optimal membrane positions of membrane-associated proteins 
which are important for biological function [38].  The method used here for membrane 
positioning is based on the minimization of the transfer energy of the protein from water 
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to a planar hydrophobic slab, which is a crude approximation of the membrane bilayer.  
The original method employed decadiene as a representation of the planar slab.  
However, in an updated method, the decadiene was replaced with 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) [38].    
The structures in Figure 6 were obtained from the OPM database which depicts 
PITPα in both the ligand-bound and ligand-free conformations with respect to a 
membrane bilayer. By visual observations, both W203 and W204 appear to be buried 
deeper into the membrane bilayer when PITPα is in the open conformation as opposed to 
the closed conformation.    Theoretical calculations revealed that the protein depth with 
respect to the membrane is 2.3 ± 1.9 Å in the closed conformation compared to 5.3 ± 1.4 
Å in the open conformation [39].  This information provides a plausible explanation for 
PITPs to have a higher binding affinity to membranes in the open conformation where it 
can either extract or deposit the phospholipid ligand.  In contrast, in the closed 
conformation, PITPs would penetrate the membrane bilayer to a lesser extent, which 
implies a lower binding affinity for the membrane bilayer.  This in turn promotes the 
ligand-bound PITP to dissociate and target the next binding site.   
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Figure 6: Orientation of PITPα in membranes – closed (A) versus open (B) 
conformation.   
The blue dots are a representation of the calculated membrane bilayer.  Both W203 and 
W204 are shown in stick form.  Calculated protein depth for (A) was 2.3 ± 1.9 Å and for 
(B) was 5.3 ± 1.4 Å.  Structures were generated using the PYMOL software obtained 
from the OPM website.   
 
In addition to the double tryptophan residues, the lipid-exchange loop also 
appears to penetrate the membrane bilayer.  Tilley et al. performed a mutational analysis 
on F72 located within this loop, which has the most likelihood to have membrane 
interaction properties.  The F72A mutant was completely functional in the lipid binding 
and transfer assay [30].  This implied that the lipid-exchange loop is not critical for PITP 
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membrane docking compared to W203 and W204.  Tryptophan residues are commonly 
associated with membrane interactions due to their physicochemical properties [40].  It is 
therefore proposed that insertion of both W203 and W204 into the membrane bilayer may 
cause an indirect perturbation of the ‘lid’ region eliciting a conformational change from 
the closed to the open state.  In fact, it has been observed that one or two tryptophan 
residues at these positions are conserved in most of the PITP members [27].   
1.4.4 PITP Ligand Binding: PC versus PI Binding 
Observations of the closed conformation of PITPα loaded either with PC or PI 
revealed that both phospholipid molecules occupy the same shape within the lipid-
binding pocket.  The main difference between the two structures, PC-PITPα and PI-
PITPα, is that PI makes more hydrogen bond contacts with specific amino acids within 
the polar lipid-binding pocket via its inositol head-group [27, 30].  This evidence 
accounts for the higher affinity of PITPs for PI compared to PC, nearly 16-fold greater as 
determined through relative affinities [20, 41].  To date, no actual Kd values have been 
reported for PITP binding to its ligands.   In mammalian cells, PC makes up about 50 
mol% of cellular phospholipids while PI makes up approximately 15 mol% [5].  
Therefore, it is plausible that PITP’s higher affinity for PI compensates for the lipid 
distribution of PI in mammalian cells.   
The amino acid residues that contact the phospholipid head-group can be divided 
into three main groups: (i) residues that contact both PC and PI; (ii) residues that are 
important for PI binding; and (iii) residues that are important for PC binding – Figure 7.  
The residues that recognize both PC and PI do so by making contacts with the phosphate 
moiety.  Specifically, Q22 and T114 form hydrogen bonds to the phosphate moiety via a 
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water molecule while T97 and K195 directly hydrogen bond to the phosphate moiety [27, 
30, 34].   
The residues that have been identified that are unique for the binding of PI include 
T59, K61, E86 and N90.  These four residues are located on two separate β-strands and 
are conserved in all PITP proteins [34].  Besides interacting with the head-group of PI, 
both T59 and E86 also interact with the head-group of PC but in distinct ways.  Therefore 
mutation of either T59 or E86 affects both PI and PC binding.  However, the effect of the 
mutation is dependent on the type of amino acid substitution.  In contrast, mutation of 
either K61 or N90 results in a decrease of PI binding and transfer with K61 providing the 
most significant loss.  PC binding and transfer remained unaffected upon mutation of 
either K61 or N90.  Hence, it can be inferred that both K61 and N90 are suitable residues 
for examining PI and PC binding and transfer by PITPs since these residues are able to 
differentiate between PI and PC binding [23, 27, 30].    
 
 
Figure 7: The lipid binding site of PITPα with PI (A) and PC (B). 
The four residues that contact the phosphate moiety of the phospholipid ligand include 
Q22, T97, T114 and K195.  The residues important for PI binding include T59, K61, E86 
and N90.  C95 that is important for PC binding is also shown.  (Reproduced with 
permission from reference 27)   
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C95 is a residue that is important for PC binding.  C95 resides in the lipid-binding 
cavity and hydrogen bonds to the PC head-group indirectly via a water molecule.  
Mutation of this residue to threonine and/or alanine reduced PC but not PI transfer.  C95 
is conserved only in the Class I PITPs.  In Class II PITPs C95 is replaced by threonine 
suggesting that PC binding and transfer may not be essential for the Class II PITPs [34].  
Another residue that has been identified to play a role in PC binding is F225.  When 
phenylalanine was replaced with leucine, a small aliphatic residue, as found in rodent 
PITPβ, PC transfer activity was lowered by nearly half compared to PITPα [33].  Similar 
to C95, F225 is conserved in Class I but not Class II PITPs.  In Class II PITPs, residue 
225 is variable in different PITPs [34].  For example, human RdgBα possess an alanine at 
this position while human RdgBβ contains a glycine; both residues contribute to a lower 
PC transfer activity in human RdgB proteins [27].  This suggests that the human RdgB 
proteins may play a lesser role in PC transfer compared to the Class I PITPs. 
1.4.5 PITP Lipid Exchange Model 
Studies show that PITPs is linked to the production of phosphoinositides.  One 
such study revealed that both PITPα and PITPβ enhanced the phosphorylation of PI to 
PI(3)P using an in vitro lipid kinase assay [34].  In addition, the yeast PITP, Sec14p, was 
also able to enhance the production of PI(3)P using the same assay.  Sec14p possess a 
similar biochemical activity as PITPs but does not share any sequence or structural 
homology [34].  It was also observed that phosphoinositide production was only 
enhanced in the presence of wild type PITPs and not PITP mutants that lack PI binding 
and transfer activity.  Therefore, the PI binding and transfer activity is crucial for the 
generation of phosphoinositides [34].   
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The molecular mechanism for PITPs remains to be fully established.  So far, two 
models have been proposed to explain the molecular mechanism of PITPs: the PI delivery 
model and the PI presentation model – Figure 8 [34].  The PI delivery model suggests 
that the main role of PITPs is to simply transfer PI from the ER to other non-ER 
membrane compartments.  In this manner, membranes that lack and require PI are 
ensured a constant supply of PI.  On the other hand, in the PI presentation model, instead 
of delivering PI to the membrane, a PITP presents its PI ligand to lipid kinases for 
phosphorylation to occur [34, 42-43].  As of yet, there is no concrete evidence to prove 
one model over the other. 
 
Figure 8: Proposed molecular mechanisms of PITPs. 
A – The lipid delivery model; PITP delivers its phospholipid ligand directly to 
membranes.  B and C – The lipid presentation model; PITP presents PI cytosolic PI 3-
kinase and membrane-bound PI 4-kinase for phosphorylation to occur.  (Reproduced with 
permission from 31) 
 
Structural analyses and in vitro studies both indicated that PITPs are designed to 
bind and transfer lipids.  However, a lipid exchange activity has not been previously 
shown in intact cells.  On the basis of this query, Shadan et al. carried out investigations 
that showed membrane interactions by PITPα and PITPβ in intact cells.  Their study 
involved using N-ethylmaleimide (NEM) as a tool to determine PITPs’ membrane 
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association in intact cells [36].  C95 located in the lipid-binding pocket of PITP can be 
covalently modified by NEM.  Since C95 is buried deep in the lipid-binding cavity, NEM 
can only access C95 when PITP is in the open conformation.  In other words, C95 is only 
accessible to NEM when PITP is undergoing lipid exchange at the membrane [36].  The 
outcome of this study showed that PITPs are continuously associating with membranes as 
determined by the amount of protein retained in the membrane versus cytosolic fractions 
[36].  Interestingly, PITPβ appeared to have a higher propensity for membrane 
interactions compared to PITPα.  Within a 10 minute time frame, nearly 90 % of PITPβ 
interacted with membranes whereas only 50 % of PITPα was found to be membrane 
associated [36].  Moreover, when the mutant form of PITP was used (W203/W204A), no 
membrane interaction was observed.  This piece of evidence further verifies the 
significance of W203 and W204 in the membrane docking process of PITP [36].  The 
data provided by Shadan et al. provides a basis that PITPs are likely to function as LTPs 
– in other words PITPs delivers PI from one membrane site to another.   
Thus the current lipid exchange model of PITPs can be described as follows – 
Figure 9.  PITPs transfers PI/PC in the closed conformation shielding the phospholipid 
ligand from the surrounding aqueous environment.  Upon docking to a membrane via the 
two tryptophan residues, PITPs take on the open conformation allowing the exchange of 
PI for PC or vice versa.  PITPs then revert back to the closed conformation and diffuse 
away from the membrane [36].   
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Figure 9: Proposed lipid exchange model by PITPs. 
PITPs transfer either PI/PC in the closed conformation.  PITPs docking unto membranes 
are aided by W203 and W204 residues and consequently PITP adopts an open 
conformation allowing lipid exchange to occur.  PITPs then take on the closed 
conformation with its new ligand and diffuse away.  (Reproduced with permission from 
reference 32)   
 
1.5 Drosophila RdgBα 
 
 
Figure 10: The domain structure of Drosophila RdgBα. 
RdgBα comprises an N-terminal PITP domain, a calcium binding domain and six 
hydrophobic regions for membrane association.  In addition, RdgBα also holds a metal 
binding site (DDHD) and a PYK-2 domain for interaction with protein tyrosine kinases.  
(Reproduced with permission from reference 44) 
 
Retinal degeneration B (RdgB) is a name derived from a Drosophila protein 
mutant whose phenotype exhibits degeneration of photoreceptors.  The gene encodes a 
160 kDa protein referred to as Drosophila melanogaster RdgBα [45-46].  RdgBα is a 
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multi-domain protein with an N-terminal PITP domain (281 residues) which shares about 
40 % sequence identity with PITPα – Figure 10 [47].  The PITP domain has been shown 
to possess PC/PI binding and transfer activity [46-47].  In addition to the PITP domain, 
RdgBα contains a short acidic region of 15 amino acid residues and six small 
hydrophobic domains.  The acidic region, enriched in glutamic and aspartic acid residues, 
is proposed to be involved in calcium binding while the hydrophobic domain is thought 
to interact with membranes [44].  RdgBα also holds a DDHD domain that may be 
involved in metal binding and a PYK-2 binding domain.  The PYK-2 binding domain is 
believed to aid in association with protein tyrosine kinases [44].  The isolation of RdgBα 
consequently led to the discovery and nomenclature of the human Class II PITPs.  
Drosophila photoreceptor cells are polarized cells that contain an apical domain 
known as the rhabdomere – Figure 11.  The rhabdomere is composed of microvilli and is 
the site for PI(4,5)P2 hydrolysis.  RdgBα is located on a region known as the 
subrhadomeric cisternae (SRC) [27, 44].  The SRC is located in close proximity to the 
rhabdomere and is continuous with the ER of the photoreceptor cell, where PI synthesis 
occurs.  Hydrolysis of PI(4,5)P2 by phospholipase Cβ, with the assistance of the G-
protein, Gq, is part of the phototransduction pathway in Drosophila and is initiated by 
rhodopsin [27, 44].  The phototransduction pathway consumes PI(4,5)P2 generating both 
inositol 1,4,5 triphosphate (PI3) and DAG.  Therefore the levels of PI(4,5)P2 must be 
replenished during cell signaling.  DAG can be recycled to form PI by the following 
enzymes: DAG kinase (RdgA), CDP-DAG synthase (cds) and PI synthase (PIS).  These 
enzymes are located in the SRC and mutations in these enzymes lead to retinal 
degeneration – Figure 11 [27].  As of yet, it is still not understood how DAG is 
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transported to the SRC.  Since RdgBα is located at the SRC it is proposed that RdgBα 
functions to deliver PI to the rhabdomere to maintain PI(4,5)P2 levels [27, 44].  The PITP 
domain of RdgBα alone has shown the ability to prevent photoreceptor degeneration in 
mutant flies, rdgB
2
, which are characterized by retinal degeneration [47].  This piece of 
evidence suggests that the main function of RdgBα is PI transfer.   
  
 
Figure 11: Proposed function of RdgBα in Drosophila phototransduction. 
Photoreceptor cells of Drosophila contain an apical domain (rhabdomere) which is 
composed of microvilli.  Phototransduction, initiated by rhodopsin (Rh), takes place at 
the microvilli and involves PI(4,5)P2 hydrolysis by PLCβ via G-protein, Gq.  Depletion of 
PI(4,5)P2 requires replenishing of PI in the rhabdomere.  RgdBα is located in the SRC 
and is proposed to supply PI to the rhabdomere via its PITP domain.  At the rhabdomere, 
it is believed that PI is first converted to PI(4)P and subsequently PI(4,5)P2.  (Reproduced 
with permission from reference 27) 
 
1.6 Protein-Membrane Interactions 
Recruitment of soluble proteins to membranes is an integral part of many 
biological processes including cell signaling and membrane trafficking [48].  Peripheral 
proteins can interact reversibly with lipid membranes through one of these methods:  (i) 
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recognition of lipid species, predominantly phosphoinositides, by lipid-binding domains; 
(ii) insertion of an amphipathic helix or a hydrophobic loop; and (iii) recognition of 
physicochemical parameters of the membrane including electrostatics, curvature or lipid 
packing [49-51].   
1.6.1 Recognition of Lipid Species by Lipid Binding Domains 
To date, at least 10 different globular lipid-binding domains have been identified 
and are being investigated.  While most of these domains target phosphoinositides, a 
handful of these domains target other lipid species that include phosphatidylserine (PS) 
and phosphatidic acid (PA) [52].  The interaction between these lipid-binding domains 
and membranes can be highly specific or non-specific.  The highly specific association 
usually involves recognition of a specific lipid species within the membrane while the 
non-specific interaction involves attraction to a physical property of the membrane such 
as charge and/or curvature [52].  The first phosphoinositide-binding domain reported was 
the ‘pleckstrin homology’ or PH domain [52].  The designation of the PH domain stems 
from the identification of an amino acid sequence that occurs twice in pleckstrin, the 
major protein kinase C (PKC) substrate in platelets [52].  The PH domain is conserved 
among a large number of proteins.  For example, the PLCδ1 PH domain binds PI(4,5)P2 
and its head-group IP3 while that of Akt/PKB (protein kinase B) binds both PI(3,4,5)P3 
and PI(3,4)P2 [49].  An example of a non-phosphoinositide lipid-binding domain is the 
C2 domain found in PKCα.  This C2 domain is a phosphatidylserine-binding domain 
[52].   
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1.6.2 Insertion of Amphipathic Helix or Hydrophobic Loop 
 In addition to lipid recognition by protein domains, the direct protein insertion 
into membranes is another type of protein-membrane interaction.  Proteins that employ 
this method of interaction generally utilize an amphipathic helix or a hydrophobic loop 
for membrane insertion [51].  When the amphipathic helix is used, the helix is inserted 
into the membrane with the hydrophilic surface facing the cytosol while the hydrophobic 
surface is buried in the membrane hemilayer [51].  An example of a protein that exploits 
this type of protein-membrane interaction is ArfGAP1 (ADP-ribosylation factor GTPase-
activating protein 1) which is involved in COPI coat disassembly.  ArfGAP1 have been 
found to contain an amphipathic lipid packing sensor (ALPS) motif, which appears 
unstructured in solution.  However, upon binding to membranes, this motif forms an 
amphipathic helix that has a propensity for membrane curvature and loosely packed lipids 
[51].    
1.6.3 Recognition of Physicochemical Parameters of the Membrane by Proteins 
A third mechanism employed by peripheral proteins in membrane interactions 
involves the recognition of the membrane’s physicochemical properties, which includes 
charge, lipid packing, and curvature.  Biological membranes contain varying amounts of 
anionic lipids largely PS, PI, and phosphoinositides.  Protein-membrane association is 
thus facilitated via electrostatic interactions between anionic lipids and cationic patches 
located on peripheral proteins.  However, electrostatic interactions alone are inadequate 
in anchoring peripheral proteins to membrane surfaces [50].   Instead it has been 
suggested that electrostatic interactions may direct initial protein docking unto 
membranes.  Consequently, hydrophobic insertion is required to form a stable membrane 
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interaction [50].  The glycolipid transfer protein (GLTP) is an example of a LTP whose 
initial binding to membranes is influenced by electrostatic interactions.  GLTP is a 24 
kDa protein that transfers glycolipids between membrane compartments in vitro and is 
positively charged at neutral pH (pI=9.0) [53].  Studies revealed that the presence of 
negatively charged lipids increases the affinity of GLTP for lipid membranes [54].  In 
addition to electrostatic interactions, it has been shown that a tryptophan residue, W142, 
is also important for GLTP’s membrane interaction [55].   
Lipid-packing defects in membranes are imperfections in the geometrical 
arrangement of lipid molecules [49].  Lipid-packing defects are brought about by the 
inherent shape of non-cylindrical lipids.  For example, phosphatidylethanolamine (PE) 
adopts a conical shape due to its smaller head-group in comparison to its fatty-acid tail 
[49].  Lysophosphatidylcholine (LPC) on the other hand, possesses an inverted cone 
shape due to its larger head-group relative to the single acyl chain [56].  Lipid packing 
defects in membranes are also influenced by the fatty acyl chains.  Fatty acyl chains that 
contain a ‘kink’ due to the presence of double bonds such as the oleyl chain (C18:1) are 
thought to occupy a larger conformational space due to mobile bond rotation next to the 
double bonds compared to fatty acyl chains that lack a ‘kink’.  Therefore, lipid packing in 
membranes is dependent on two factors: 1) the ratio between small and large lipid head-
groups; and 2) the ratio between saturated and unsaturated fatty acyl chains [52].  
Examples of proteins whose membrane interactions are influenced by lipid-packing 
include GLTP and ceramide transfer protein (CERT).  GLTP has shown to preferentially 
bind to tightly-packed membranes.  However, GLTP-mediated transfer activity is greater 
from more fluid membranes [57].  CERT, a 68 kDa protein, consists of three domains: 
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steroidogenic acute regulatory protein-related lipid transfer (START) domain, PH domain 
and FFAT motif.  The START domain located at the C-terminal end is responsible for 
ceramide transfer.  The PH domain located at the N-terminal end is involved in protein 
binding to the Golgi while the FFAT motif targets the protein to the ER [58].  Studies 
reveal that the intermembrane ceramide transport by CERT is preferred when ceramide is 
present in a fluid environment [58].   
 Biological membranes are understood to be dynamic in nature.  At any given 
time, numerous processes are taking place from membrane remodeling to membrane-
protein interactions.  The majority of these activities influence local membrane curvature.  
There are several means by which changes to membrane curvature can arise including 
lipid metabolism, protein scaffolding and protein interaction [51].   
The inherent shape of each lipid molecule is different and is chiefly influenced by 
the compatibility between the size of the polar head-group and its fatty acyl chain [59].  A 
lipid molecule adopts a cylindrical shape when both the head-group and hydrophobic tail 
are compatible in cross-sectional size.  A lipid molecule is conical when the tail is wider 
or inverted conical when the head-group is larger [59].  Enrichment of the membrane 
with any of these lipids in turn influences the local membrane curvature.  While 
cylindrical-shaped lipids give rise to a planar bilayer, both conical and inverted conical 
lipids form negatively curved and positively curved monolayers respectively [59].  
Enrichment of the membrane with any one of these lipids is brought about by an increase 
in lipid metabolism.  Lipid metabolism in turn is achieved by means of lipid synthesis 
and/or lipid transport [51].   
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Membrane curvature can also be brought about by protein scaffolding.  The most 
well-studied proteins that act as protein scaffolds include coat proteins such as clathrin, 
COPI and COPII (coat protein complex II) [60].  Clathrin plays a role in endocytosis, a 
process that involves the formation of vesicles from the plasma membrane to form 
endosomes.  COPI/II proteins on the other hand mediate vesicle transport between the ER 
and Golgi apparatus [51].  These coat proteins deform the membrane by polymerizing 
into curved structures without direct membrane interactions.  Instead, they interact with 
membranes via adaptor or cargo proteins [51, 60].   
Finally, the third mechanism that induces membrane curvature involves direct 
protein interaction.  Two well-known proteins that perform this function include the BAR 
proteins and the ArfGAP1 protein [51].  BAR proteins contain Bin-Amphiphysin-Rvs 
(BAR) domains, which are banana-shaped lipid binding domains.  These lipid-binding 
domains associate with membranes via their concave surface [60].  BAR proteins mainly 
bind to membranes through electrostatic interactions.  In contrast, the ArfGAP1 protein 
utilizes an amphipathic helix to induce membrane curvature by direct protein insertion 
into the membrane as described previously [51].   
1.7 Research Outline 
As mentioned previously, there are two theories regarding the molecular function 
of PITPs: the PI delivery model and the PI presentation model.  The focus of this thesis is 
on investigating the ligand transfer mechanism by PITPs in order to gain a better 
understanding of the molecular function of PITPs.  As yet, the details of the ligand 
transfer mechanism by PITPs remain to be fully established.  Since PITPs lack membrane 
targeting signals, unlike other multi-domain LTPs, the question that needs to be 
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addressed is – how do PITPs recognize one membrane compartment from another during 
ligand transfer?  One way of approaching this question is to examine the types of 
membrane environment that favor PITP binding to membranes.  Specifically the role of 
lipid composition and the physicochemical parameters of membranes are investigated 
here to determine their effects on PITP binding to membranes.   
At present there are several methods that can be used to study protein-lipid 
interactions including nuclear magnetic resonance (NMR) spectroscopy and differential 
scanning calorimetry (DSC) [61].  However, in this thesis, two main techniques are used: 
dual polarization interferometry (DPI) and fluorescence spectroscopy.   
1.7.1 Dual Polarization Interferometry (DPI) 
DPI is an optical technique that employs a sensor chip made of silicon oxynitride.  
The sensor chip consists of two optical waveguides stacked on top of each other; the top 
layer being the sensing waveguide while the bottom layer serves as the reference 
waveguide [62].  The surface of the sensing waveguide contains two etched sample wells 
where the analyte of interest may bind.   
The principle of DPI can be explained as follows.  Polarized laser light enters one 
end of the sensor chip, which then produces an interference pattern in the far-field.  The 
interference pattern formed is dependent upon the phase relationship of the light that 
travels through and emerges from the two waveguides.  When no analyte is bound to the 
surface of the sensor chip, light passing through both waveguides is in phase [62].  
However, when an analyte is bound to the surface of the sensor chip, light passing 
through both waveguides is no longer in phase due to the change in refractive index at the 
sensing waveguide surface.  Consequently, the interference pattern that is formed also 
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changes.  In DPI two parameters of the polarized light are used instead of one – 
transverse electric (TE) and transverse magnetic (TM) – which provides two independent 
measurements.  The resulting measurements can then be resolved into thickness, 
refractive index and mass values [62-63].   
 
 
Figure 12: DPI principle.   
Polarized light from a laser source passes through the sensor chip producing an 
interference pattern in the far-field.  The interference pattern changes as analyte is bound 
to the sensor chip surface.  (Reproduced with permission from reference 64)  
 
In this thesis, the binding affinity of PITPs to immobilized planar lipid layers will 
be examined.  Here, lipid vesicles will first be adsorbed and unrolled unto the sensor chip 
surface to produce a planar lipid layer.  Consequently the interaction between PITPs and 
the lipid layer will be monitored by measuring the mass of PITPs bound to the chip 
surface.   
1.7.2 Fluorescence Resonance Energy Transfer (FRET) Assay 
In addition to measuring the binding affinity of PITPs to membranes, the ligand 
transfer rate of PITPs to membranes will also be examined.  In order to achieve this, a 
fluorescence resonance energy transfer (FRET) based transfer assay will be employed.  
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FRET is the transfer of energy from an excited donor molecule to an acceptor molecule 
[65].   Energy transfer is manifested by the decrease in fluorescence (quenching) of the 
donor molecule or an increase in fluorescence of the acceptor molecule.  However, the 
acceptor molecule does not necessarily have to be fluorescent.  In order for FRET to 
occur, the fluorescence emission spectrum of the donor molecule must overlap the 
absorption or excitation wavelength of the acceptor molecule.  Furthermore, both the 
donor and acceptor molecules must be in close proximity, typically between 1 – 10 nm 
[65].   
In the FRET-based transfer assay, the rate at which PITPs can deliver its ligand to 
lipid vesicles of different compositions and size will be determined.  In contrast, a FRET-
based pick up assay will also be utilized to measure the rate at which PITP can extract its 
ligand from lipid vesicles.  By employing both techniques, the aim of this thesis is to gain 
a better understanding of the interactions between PITPs and membranes in the hope of 
further understanding the ligand transfer mechanism of PITPs.   
The proteins that will be examined in this thesis include the human PITPα and 
PITPβ.  Three PITPα mutants will also be investigated which are W203A/W204A, K61A 
and C95A.  While the W203A/W204A mutant lacks the capability to bind to membranes, 
K61A and C95A are unable to bind PI and PC respectively.  Lastly, the Drosophila 
RgdBα and its mutant form Y210A/W211A, which is thought to mimic the human PITPα 
W203A/W204A mutant, will also be tested here.  It should be noted that only the PITP 
domain of the RdgBα proteins will be examined here. 
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2. MATERIALS AND METHODS 
2.1 Chemicals and Reagents 
2.1.1 DNA Transformation, Bacterial Cell Culture and Protein Expression 
Ampicillin (BioShop, Burlington, ON, Canada); 100 mg/mL in MilliQ (ultrapure 
water – 18.2 MΩ.cm) water 
Chloramphenicol (BioShop, Burlington, ON, Canada); 25 mg/mL in MilliQ water  
Sodium Chloride [NaCl] (Bioshop, Burlington, ON, Canada) 
Yeast Extract (BioShop, Burlington, ON, Canada) 
Tryptone (BioShop, Burlington, ON, Canada) 
Agar (BioShop, Burlington, ON, Canada) 
Isopropyl-D-thiogalactoside [IPTG] (BioShop, Burlington, ON, Canada); 1M in 
MilliQ water 
2.1.2 DNA Isolation, DNA Digestion and DNA Gel Electrophoresis 
NdeI Restriction Enzyme (New England BioLabs, Ipswich, MA, USA) 
HindIII Restriction Enzyme (New England BioLabs, Ipswich, MA, USA) 
DpnI Restriction Enzyme (New England BioLabs, Ipswich, MA, USA) 
Boric Acid (Sigma-Aldrich, Oakville, ON, Canada) 
Ethylenediaminetetraacetic acid [EDTA] (BioShop, Burlington, ON,Canada) 
Agarose (BioShop, Burlington, ON, Canada) 
HighRanger 1kb DNA Ladder (Norgen, Thorold, ON, Canada) 
2.1.3 Polymerase Chain Reaction 
PfuTurbo DNA Polymerase (Agilent Technologies, Santa Clara, CA, USA) 
PCR Nucleotide Mix (Boehringer Mannheim, Laval, QC, Canada) 
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2.1.4 Protein Purification and Quantitation 
 TALON Metal Affinity Resin (Clontech, Moutain View, CA, USA) 
 Sodium Phosphate Monobasic (BioShop, Burlington, ON,Canada) 
 Imidazole (BioShop, Burlington, ON, Canada) 
 Glycerol (BioShop, Burlington, ON, Canada) 
 Triton X-100 (Sigma-Aldrich, Oakville, ON, Canada) 
 Deoxyribonuclease I (Invitrogen, Burlington, ON, Canada) 
ProteoGuard EDTA-Free Protease Inhibitor Tablets (Clontech, Mountain View, 
CA, USA) 
 2-(N-Morpholino)ethanesulphonic acid [MES] (BioShop, Burlington, ON, 
 Canada) 
Piperazine-N,N-bis(ethanesulphonic acid) [PIPES] (BioShop, Burlington, ON, 
Canada) 
 Potassium Chloride [KCl] (Caledon Laboratories, Georgetown, ON, Canada) 
 Sodium Azide (BioShop, Burlington, ON, Canada) 
 Bradford Reagent (Sigma-Aldrich, Oakville, ON, Canada) 
2.1.5 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Tris(hydroxymethyl)aminomethane [Tris] (BioShop, Burlington, ON, Canada) 
Glycine (BioShop, Burlington, ON, Canada) 
Sodium Dodecyl Sulfate [SDS] (Sigma-Aldrich, Oakville, ON, Canada) 
Dithiothreitol [DTT] (Sigma-Aldrich, Oakville, ON, Canada) 
Bromophenol Blue (Sigma-Aldrich, Oakville, ON, Canada) 
Ammonium Persulfate (BioShop, Burlington, ON, Canada) 
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Acrylamide/Bis-acrylamide 30 % (w/v) (BioShop, Burlington, ON, Canada) 
Tetramethylethylenediamine [TEMED] (Bio-Rad, Hercules, CA, USA) 
Methanol (Fisher Scientific, Fair Lawn, NJ, USA) 
Acetic Acid (Caledon Laboratories, Georgetown, ON, Canada) 
ProtoBlue Safe (Colloidal Coomassie G-250 Stain) (National Diagnostics, 
Atlanta, GA, USA) 
Pre-stained Protein Marker Broad Range (New England BioLabs, Ipswich, MA, 
USA) 
2.1.6 Western Blot 
 Fluka Skim Milk Powder (Sigma-Aldrich, Oakville, ON, Canada) 
 Tween-20 (Sigma-Aldrich, Oakville, ON, Canada) 
Anti-His (Mouse) antibody [recognizes (histidine)6-tagged proteins] (GE 
Healthcare Life Sciences, Baie d’Urfe, QC, Canada) 
 Anti-mouse IgG HRP conjugate (Promega, Madison, WI, USA) 
3,3′,5,5′-Tetramethylbenzidine (TMB) liquid substrate system for membranes 
(Sigma-Aldrich, Oakville, ON, Canada) 
2.1.7 Fluorescence-based Binding Assay 
NBD C12-HPC (2-(12-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)amino)Dodecanoyl-1-
Hexadecanoyl-sn-Glycero-3-Phosphocholine) [NBD-PC] (Life Technologies, 
Burlington, ON, Canada) 
Sucrose (BioShop, Burlington, ON, Canada) 
2.1.8 Reduction of NBD-PC by Sodium Hydrosulfite 
 Sodium Hydrosulfite (Sigma-Aldrich, Oakville, ON,Canada) 
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2.1.9 Fluorescence Resonance Energy Transfer (FRET) Assays 
L-α-phosphatidylcholine (Liver, Bovine) [Liver PC] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
L-α-phosphatidylinositol (Liver, Bovine) [Liver PI] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
L-α-phosphatidylserine (Brain, Porcine) [Brain PS] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
1,2-dioleoyl-sn-glycero-3-phosphate [18:1 PA] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B 
sulfonyl)   [18:1 Liss Rhod PE] (Avanti Polar Lipids Inc., Alabaster, AL, USA) 
L-α-phosphatidylinositol-4-phosphate (Brain, Porcine) [Brain PI(4)P] (Avanti 
Polar Lipids Inc., Alabaster, AL, USA) 
L-α-phosphatidylinositol-4,5-bisphosphate (Brain, Porcine) [Brain PI(4,5)P2] 
(Avanti Polar Lipids Inc., Alabaster, AL, USA)  
Phosphatidylinositol 3,4,5-trisphosphate diC16  [PI(3,4,5)P3 diC16] (Echelon 
Biosciences Inc., Salt Lake City, UT, USA) 
(N-(6-Tetramethylrhodaminethiocarbamoyl)-1,2-Dihexadecanoyl-sn-Glycero-3-
Phosphoethanolamine) [TRITC DHPE] (Life Technologies, Burlington, ON, 
Canada) 
2.1.10 Dual Polarization Interferometry 
1, 2-dioleoyl-sn-glycero-3-phosphocholine [DOPC] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
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1, 2-dioleoyl-sn-glycero-3-phospho-L-serine [DOPS] (Avanti Polar Lipids Inc., 
Alabaster, AL, USA) 
1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine [DOPE] (Avanti Polar Lipids 
Inc., Alabaster, AL, USA) 
2.2 Buffers and Solutions 
2.2.1 DNA Transformation 
LB-Amp agar plates: 5 g/L NaCl, 5 g/L yeast extract, 10 g/L tryptone, 15 g/L agar 
supplemented with 100 μg/mL ampicillin  
LB-Amp/Chlor agar plates: 5 g/L NaCl, 5 g/L yeast extract, 10 g/L tryptone, 15 
g/L agar supplemented with 100 μg/mL ampicillin and 25 μg/mL 
chloramphenicol 
2.2.2 DNA Agarose Gel Electrophoresis 
10X TBE: 108 g/L Tris, 55 g/L boric acid, 40 mL of 0.5 M EDTA, pH 8 
2.2.3 Bacterial Cell Culture and Protein Expression 
 Luria Bertani (LB) Broth: 5 g/L NaCl, 5 g/L yeast extract, 10 g/L tryptone 
LB-Amp/Chlor medium: LB medium supplemented with 100 μg/mL ampicillin 
and 25 μg/mL chloramphenicol 
2.2.4 Protein Purification 
Resuspension Buffer: 50 mM potassium phosphate monobasic, 300 mM NaCl, 10 
% glycerol, pH 7.5 
Wash Buffer: 50 mM potassium phosphate monobasic, 300 mM NaCl, 20 mM 
imidazole, 10 % glycerol, pH 7.5 
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Elution Buffer: 50 mM potassium phosphate monobasic, 300 mM NaCl, 150 mM 
imidazole, 10 % glycerol, pH 7.5 
Resin Regeneration Buffer: 20 mM MES, 100 mM NaCl, pH 5 
Storage Buffer: 20 % ethanol 
PIPES Buffer: 20 mM PIPES, 137 mM NaCl, 2.7 mM KCl, pH 6.8 
10X Phosphate Buffered Saline (PBS): 137 mM NaCl, 2.7 mM KCl, 10 mM 
potassium phosphate dibasic, 1.8 mM potassium phosphate monobasic, pH 7.4 
Storage Buffer: 1X PBS supplemented with 0.02 % sodium azide 
2.2.5 SDS-PAGE 
Stacking Buffer: 0.5 M Tris, pH 6.8 
Separating Buffer:  1.5 M Tris, pH 8.8 
5X Running Buffer: 125 mM Tris, 960 mM glycine, 0.5 % SDS, pH 8.3 
5X Loading Dye: 50 mM Tris, 16 % glycerol, 16% SDS (10 %), 0.02 % DTT, 
0.08 % bromophenol blue (1 %) 
Gel Drying Solution: 40 % methanol, 10 % glycerol, 7.5 % acetic acid 
2.2.6 Western Blot 
 Native PAGE Running Buffer: 0.025 M Tris, 0.192 M Glycine, pH 8.3  
Blotting Buffer: 80 % Native PAGE running buffer, 20 % methanol 
Blocking Buffer: 10 % skim milk powder, 10 mM Tris, 150 mM NaCl, 0.05 % 
Tween-20, pH 8 
TBST Buffer: 10 mM Tris, 150 mM NaCl, 0.05 % Tween-20, pH 8 
2.2.7 Fluorescence-based Binding Assay 
SET Buffer: 250 mM sucrose, 100 mM KCl, 50 mM Tris, 1 mM EDTA, pH 7.4 
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TKE Buffer: 50 mM Tris, 100 mM KCl, 1 mM EDTA, pH 7.4  
2.2.8 FRET Assays 
 SET Buffer: 250 mM sucrose, 100 mM KCl, 50 mM Tris, 1 mM EDTA, pH 7.4 
 TKE Buffer: 50 mM Tris, 100 mM KCl, 1 mM EDTA, pH 7.4 
2.2.9 Dual Polarization Interferometry 
 DPI Buffer: 10 mM potassium phosphate dibasic, 137 mM NaCl, pH 7.4 
 Calibration Solutions: 80 % ethanol, MilliQ water 
 Wash Solutions: 2 % SDS, 80 % ethanol, MilliQ water 
2.3 Materials and Equipment 
 QIAprep Spin Miniprep Kit (Qiagen, Germantown, MD, USA) 
PD-10 Desalting Columns (GE Healthcare Life Sciences, Baie d’Urfe, QC, 
Canada) 
 New Brunswick Incubator shaker I-26 (Eppendorf, Mississauga, ON, Canada) 
 VWR Gravity Convection Incubators (VWR, Mississauga, ON, Canada) 
MLS-3751L-PE Laboratory Autoclave (Panasonic Biomedical, Loughborough, 
Leicestershire, UK) 
PURELAB Flex (ELGA Labwater, Mississauga, ON, Canada) 
Sub-Cell GT Electrophoresis Cell (Bio-Rad, Mississauga, ON, Canada) 
Hoefer Scientific PS 500 XT DC Power Supply (Hoefer Inc., Holliston, MA, 
USA) 
Mastercycler Nexus (Eppendorf, Mississauga, ON, Canada) 
Eppendorf PCR tubes 0.2 mL (Eppendorf, Mississauga, ON,Canada) 
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GENESYS 10S UV-Vis Spectrophotometer (Thermo Scientific, Waltham, MA, 
USA) 
Mini-PROTEAN III Cell (Bio-Rad, Mississauga, ON, Canada) 
Allegra X-30 Benchtop Centrifuge (Beckman Coulter, Mississauga, ON, Canada) 
IEC Micromax Microcentrifuge (Thermo Electron Corporation, Gormley, ON, 
Canada) 
Orion Dual Star Meter (Thermo Scientific, Waltham, MA, USA) 
Liposofast-Basic (Avestin, Ottawa, ON, Canada) 
Polycarbonate Filters (Avestin, Ottawa, ON, Canada) 
Nitrocellulose Membranes (Sigma-Aldrich, Oakville, ON, Canada) 
Gel Drying Film (Promega Corporation, Madison, WI, USA) 
Cryogenic Vials (Corning Inc., Corning, NY, USA) 
Quartz Cuvettes (Hellma, Concord, ON, Canada) 
NESLAB EX-111 Heating Circulator Temperature Bath (Thermo Electron 
Corporation, Gormley, ON,Canada) 
Gel Doc EZ System (Bio-Rad, Mississauga, ON, Canada) 
Rocker II Platform Rocker (Boekel Scientific, Feasterville, PA, USA) 
Roto-Torque Rotator (Cole-Parmer, Montreal, QC, Canada) 
Reax Control Vortex (Heidolph, Elk Grove Village, IL, USA) 
QuantaMaster-QM-2001-4 Spectrofluorometer (Horiba Scientific, London, ON, 
Canada) 
SFA-20 Stopped-flow (TgK Scientific Limited, Bradford-on-Avon, UK) 
Analight Bio200 (Biolin Scientific, Linthicum Heights, MD, USA) 
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Q500 Sonicator (QSonica, Newtown, CT, USA) 
Protein Solutions DynaPro-99-E (Wyatt Technologies, Santa Barbara, CA, USA)  
2.4 Software 
GraphPad Prism for Windows, Version 5.0 (GraphPad Software Inc., La Jolla, 
CA, USA) 
Image Lab Software, Version 4.1 (Bio-Rad, Mississauga, ON, Canada) 
Felix32 Spectroscopy Software, Version 1.2 (Horiba Scientific, London, ON, 
Canada) 
AnaLight Bio200, Version 2.1.0 (Biolin Scientific, Linthicum, MD, USA) 
AnaLight Explorer, Version 1.6.0.27583 (Biolin Scientific, Linthicum, MD, 
USA) 
2.5 Bacterial Strains 
BL21(DE3)pLysS-T1 Competent Cells (Sigma-Aldrich, Oakville, ON, Canada); 
stored at -80° C 
NovaBlue Singles Competent Cells (EMD Millipore, Billerica, MA, USA); stored 
at -80° C 
2.6 Bacterial Expression Vectors 
Recombinant human PITPα and PITPβ were expressed from the pRSET-C 
plasmid vector.  Similarly, recombinant Drosophila melanogaster RdgBα and the 
Y210A/W211A mutant were also expressed from the pRSETC plasmid vector.  These 
plasmids were a gift from our collaborator, Dr. Shamshad Cockcroft, University College 
London (UK).  PITP mutants were created by site-directed mutagenesis of recombinant 
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PITPα.  pRSET vectors contain an N-terminal His-tag which is used for protein 
purification purposes. 
2.7 Methods 
2.7.1 Site-Directed Mutagenesis (Production of PITPα Mutants) 
 PITPα mutants were developed according to the QuikChange protocol (Agilent 
Technologies, formerly Stratagene).  The human PITPα gene cloned into the pRSET-C 
plasmid vector was used for site-directed mutagenesis.  All primers (Table 2) were 
designed using either PrimerX or OligoPerfect Designer (Life Technologies) and were 
manufactured by Sigma-Aldrich.  PfuTurbo DNA polymerase was employed to generate 
the following mutants: C95A, K61A and W203A/W204A.  The cycling parameters 
utilized in generating the PITPα mutants are listed in Table 3.  The PCR reaction mixture 
was set up as follows: 5 μL 10X Pfu reaction buffer, 1 μL dNTP mix (10 mM), 5 μL 
forward primer (125 ng), 5 μL reverse primer (125 ng), 0.5 μL DNA template (50 ng), 
32.5 μL MilliQ water, 1 μL PfuTurbo DNA polymerase. 
The PCR products were subject to DpnI endonuclease digestion for 1 h at 37 °C 
and the presence of the PCR products were verified by gel electrophoresis.  The purpose 
of the DpnI digestion is to remove template, non-mutated DNA.  Since the template DNA 
is methylated, it is selectively digested by DpnI.  Consequently, the PCR products were 
transformed into NovaBlue competent cells for propagation.  Plasmid DNA containing 
the mutant gene of interest was then isolated from NovaBlue cells using the QIAprep 
Spin Miniprep kit and the sequence of the mutant gene was confirmed through DNA 
sequencing.  Upon confirmation, the plasmid containing the mutant gene of interest was 
then transformed into BL21(DE3)pLysS competent cells for protein expression.     
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Table 2: Oligonucleotide primers utilized for creating the PITPα mutants (sequence 
in red represents nucleotide substitutions) 
Primer Sequence (5′ - 3′) Tm 
C95A-FW AATGCTTACCCCTACGCCAGAACCGTTATTACAAATG 76.7 °C 
C95A-RV CATTTGTAATAACGGTTCTGGCGTAGGGGTAAGCATT 76.7 °C 
K61A-FW GCCAGTACACACGCGATCTACCACCTGC 79.1 °C 
K61A-RV GCAGGTGGTAGATCGCGTGTGTGTACTGGC 79.1 °C 
W203A/ 
W204A-FW 
ACCGTCAAGTTCAAGGCGGCGGGCCTGCAGAACAA 88.1 °C 
W203A/ 
W204A- RV 
TTGTTCTGCAGGCCCGCCGCCTTGAACTTGACGGT 88.1 °C 
 
 
Table 3: Cycling parameters employed for creating the PITPα mutants 
Program Cycles Temperature Time Activity 
1 1 95 °C 30 s Initial denaturation 
2 18 95 °C 30 s Denaturation 
55 °C 1 min Annealing 
68 °C 8 min Extension 
3 1 4 °C 24 hrs End 
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2.7.2 DNA Transformation 
Plasmid DNA transformation of E. coli was performed using the heat shock 
method [66].  Competent cells were obtained commercially.   NovaBlue competent cells 
were used for the purpose of DNA propagation.  This is due to NovaBlue’s high 
transformation efficiency (> 1.5 x 10
8
 cfu/µg) [67].  It also lacks the endonuclease (endA) 
and (recA) genes that enable the host strain to produce high quality plasmid DNA.  For 
recombinant protein production, BL21(DE3)pLysS competent cells were employed.  This 
strain lacks the Ion and ompT proteases that promote the production of stable 
recombinant proteins.  In addition, the BL21(DE3)pLysS cells contain an inducible T7 
RNA polymerase which is under the control of the lacUV5 promoter.  Therefore, protein 
expression is easily induced by the addition of IPTG.  The presence of the T7 lysozyme 
in BL21(DE3)pLysS cells naturally inhibits T7 polymerase which aids in a tighter 
transcriptional control and aids cell lysis.   
Competent cells were thawed on ice for 10 min.  Plasmid DNA (50 ng) was then 
added to each aliquot of cells (50 μL) and incubated on ice for 30 min.  Next, the cell 
mixture was heat shocked at 37 °C for 45 s (for BL21(DE3)pLysS cells) or at 42 °C for 
30 s (for NovaBlue cells).  The cells were then placed on ice for 2 min.  LB media (450 
μL) was added to the cell mixture and incubated at 37 °C on a shaker to allow cell 
growth.  Cells (100 – 200 μL) were then plated unto LB agar plates with the appropriate 
antibiotic for selection of colonies.  Ampicillin was used when selecting for NovaBlue 
cells while ampicillin and chloramphenicol were used for BL21(DE3)pLysS cells as 
chloramphenicol selects for the pLysS plasmid.  The plated cells were allowed to grow 
overnight at 37 °C.   
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2.7.3 DNA Isolation 
 Plasmid DNA isolation from NovaBlue cells was performed using the QIAprep 
Spin Miniprep Kit according to the manufacturer’s protocol.  Pre-cultures were grown 
overnight in LB media containing 100 μg/mL ampicillin.  Aliquots (3 mL) of culture 
were centrifuged in a microcentrifuge tube at 5000 rpm for 3 min.  The supernatant was 
removed and the cell pellet was resuspended in 250 μL of Buffer P1 containing RNase A. 
Following that, 250 μL of Buffer P2 was added and mixed by gently inverting the tube 4 
to 6 times.  350 μL of Buffer N3 was then added followed by inverting the tube 4 to 6 
times.  Next, the mixture was centrifuged at 12000 rpm for 10 min.  The supernatant was 
then applied to the QIAprep spin columns and centrifuged for 1 min at 12000 rpm.  The 
supernatant was discarded and 500 μL of Buffer PB was added to the column.  The 
column was centrifuged for 1 min at 12000 rpm.  The flow-through was discarded and 
the column was washed with 750 μL of Buffer PE.  Again, the column was centrifuged 
for 1 min at 12000 rpm.  The flow-through was discarded and the column was 
centrifuged for a further 1 min to remove residual wash buffer.  The column was then 
transferred to a 1.5 mL microcentrifuge tube and 50 μL of MilliQ water was added to the 
column to elute the plasmid DNA.  The column was allowed to stand for 1 min prior to 
centrifugation for 1 min at 12000 rpm.   
2.7.4 DNA Quantification 
 Plasmid DNA concentration was determined by means of spectrophotometric 
analysis.  DNA samples were diluted in MilliQ water in a quartz cuvette and the 
absorbance was measured at a wavelength of 260 nm.  Since the optical density of 1 
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corresponds to 50 μg/mL of double-stranded DNA, plasmid DNA concentration can be 
calculated as follows: 
[DNA] = Abs260*50 μg/mL*Dilution Factor  (1) 
2.7.5 Restriction Enzyme Digestion of DNA 
 Restriction enzyme digestion of plasmid DNA was performed to confirm the 
presence of the gene of interest (wild-type or mutant gene) within the plasmid prior to 
DNA sequencing.  A typical restriction enzyme digest performed contained the following 
components: 1 μL of DNA, 1 μL of each restriction enzyme, 2 μL of 10X restriction 
enzyme buffer, 0.5 μL BSA (if recommended) and 15.5 μL of MilliQ water to bring the 
final volume of the reaction mixture to 20 μL.  For all plasmids used in this project, a 
double restriction enzyme digest was conducted using both NdeI and HindIII.  The 
prepared sample mixture was then mixed and pulsed briefly in a microcentrifuge to 
ensure all the solution remained at the bottom of the microcentrifuge tube.  The reaction 
mixture was then incubated in a water bath at 37° C for 1 h.   
2.7.6 DNA Agarose Gel Electrophoresis 
 Typically, 1 % agarose gels were used for analyzing plasmid DNA fragments 
from restriction digests and also for examining PCR products.  Agarose gels were 
prepared by dissolving 0.5 g of agarose in 50 mL 1X TBE.  The mixture was microwaved 
for approximately 45 s or until the agarose was dissolved.  Once the mixture cooled to 
about 50° C, 25-30 μL of 500 µg/mL of ethidium bromide was added (final concentration 
of 0.2 – 0.3 μg/mL) to allow visualization of DNA.  Once the gel set, approximately 2 μL 
of gel loading buffer dye was added to 10 μL of DNA samples prior to loading onto the 
DNA gel.  DNA molecular weight markers were also loaded alongside the DNA samples.  
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The gel was run at 80 – 100 V until the gel loading buffer dye reached 5 – 10 mm from 
the bottom of the gel.   
2.7.7 DNA Sequencing 
 Sequencing of all plasmid DNA samples was performed at Robarts Research 
Institute (London, ON).   
2.7.8 Bacterial Glycerol Stocks 
 Once the sequence of the gene containing the protein of interest was confirmed, 
bacterial glycerol stocks were prepared for long-term storage of plasmids.  Colonies from 
the transformed NovaBlue or BL21(DE3)pLysS cells were picked and grown overnight 
in 10 mL of autoclaved LB broth at 37 °C.  Once bacterial growth is achieved, 750 μL of 
overnight culture was mixed with 750 μL of 30 % glycerol in a 2 mL cryogenic vial.  The 
glycerol stock was then frozen at -80 °C and kept for long-term storage.   
2.7.9 Protein Expression 
 Pre-cultures were prepared in test tubes containing 10 mL of autoclaved LB broth 
supplemented with 100 μg/mL ampicillin and 25 μg/mL chloramphenicol.  Each test tube 
was inoculated with a frozen culture of BL21(DE3)pLysS E. coli cells containing the 
desired pRSET vector.  The cultures were then grown overnight at 37°C in a test tube 
roller.  An aliquot of the overnight pre-culture (5 mL) was used to inoculate 500 mL of 
LB broth to produce a 1:100 dilution factor.  The cultures were allowed to grow in 1L 
baffled flasks at 37°C on a  shaker at 180 rpm until an OD600 of 0.4 – 0.6 was achieved.  
Following that, protein expression was induced by the addition of 0.4 mM IPTG.  The 
cultures were then allowed to grow overnight on a shaker at 28 °C except for C95A 
which was induced at 20 °C to improve protein yield.  Finally, the cells were harvested 
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by centrifugation at 4400 rpm for 15 min.  The supernatant was decanted and the cell 
pellet was stored at -80°C until further use. 
2.7.10 Protein Purification 
 The frozen cell pellet was thawed and frozen at -80°C twice to promote cell lysis.  
The cell pellet was then suspended in 10 mL of Resuspension Buffer.  In addition, 50 μL 
of Triton X-100 (final concentration of 0.5 %) was added to the suspension along with 10 
μL of DNAse (20 Units) and one tablet of Protease Inhibitor Cocktail.  The cell 
suspension was incubated for 15 min on ice.  Following that, the lysate was passed 
through an 18 ½ gauge needle attached to a 10 mL syringe approximately 10 times.  The 
cells were centrifuged at 11400 rpm for 45 min at 4°C.  If required, the supernatant 
obtained was centrifuged for a further 30 min at 11400 rpm. 
 A column containing 1 mL of Talon Metal Affinity Resin was prepared by 
equilibrating with 10 mL Wash Buffer.  All solutions were allowed to pass through the 
column by gravity flow.  The supernatant was then added to the column and allowed to 
incubate overnight on a shaker at 4°C.  Subsequently, the column was washed with 10 
mL of Wash Buffer.  Protein fractions (5 mL) were then eluted, 1 mL at a time, using 
Elution Buffer.  The column was then regenerated with 8 mL of Regeneration Buffer 
followed by 8 mL of MilliQ water.  Subsequently the resin was stored in 1 mL of 20 % 
ethanol solution. 
 A PD-10 desalting column was also prepared by equilibrating with 10 mL of 
PIPES Buffer.  Normally, the first three protein fractions obtained were added to the 
desalting column.  The protein was then eluted with 4 mL of PIPES Buffer and stored at 
4°C until further use.  The use of the desalting column is chiefly for buffer exchange 
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purposes.  Finally the column was regenerated with 10 – 20 mL of 1X PBS containing 
0.02 % sodium azide.  The column was then stored in the same solution at room 
temperature.   
2.7.11 Protein Quantitation: Bradford Assay 
 The Bradford assay was employed to determine the protein concentration from a 
given purification.  A standard curve was prepared using bovine serum albumin (BSA) 
with concentrations ranging between 0-1 mg/mL.  Typically, each standard was prepared 
by adding 50 μL of BSA solution to 1 mL of Bradford reagent.  The standards were 
prepared in plastic cuvettes and allowed to incubate for 5 min at room temperature.  The 
absorbance was then measured at 595 nm.  The concentration of the unknown protein 
samples were determined from the standard curve and the conditions used were similar to 
those of the BSA samples.   
2.7.12 Protein Characterization: SDS-PAGE Analysis 
 The purity of the proteins purified was determined by means of SDS-PAGE.  To 
achieve this analysis, a 15 % acrylamide resolving gel with a 5.5 % acrylamide stacking 
gel was used.  For protein samples of known concentrations, loading dye was added to 5 
μg samples of protein.  For protein samples of unknown concentrations, typically 6 μL of 
loading dye was added to 24 μL of protein sample.  The protein samples were then heated 
at 95 °C for 5 min to fully denature the proteins.  Subsequently, the samples were loaded 
onto the gel along with a protein molecular weight marker and allowed to run for 
approximately 2 h at 110 V.  The gels were then stained with ProtoBlue Safe Colloidal 
Coomassie G-250 Stain overnight and destained with distilled water.  The stain was 
prepared by combining one part of ethanol to nine parts of staining solution. 
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 The gels were then preserved by soaking in gel drying solution for 5-10 min along 
with gel drying film.  The gel was then assembled on top of a clean glass plate 
sandwiched between two gel drying films and allowed to air dry.   
2.7.13 Western Blotting of Purified Proteins 
 The identity of the purified protein was confirmed using Western Blot analysis.  
An SDS-PAGE was first run containing the protein of interest.  Subsequently, the protein 
was transferred from the SDS-PAGE gel to a nitrocellulose membrane as shown in 
Figure 13. 
 
Figure 13: Western Blot set-up for transferring protein from the SDS-PAGE gel to 
nitrocellulose membranes.   
 
The above set-up was prepared in a plastic dish using blotting buffer and left overnight to 
dry.  The membrane was then removed from the blotting sandwich and blocked with 30 
mL of blocking buffer for 15 min at room temperature on a rocker.  The blocked 
membrane was washed twice with 20 mL of TBST buffer (5 min per rinse).  Following 
that, the membrane was incubated with mouse anti-His antibody (1:3000 dilution in 20 
mL TBST buffer) for 30 min at room temperature on a rocker.  The membrane was then 
washed 3 times with 25 mL of TBST buffer (10 min per rinse).  Consequently, the 
membrane was incubated with anti-mouse IgG HRP (horseradish peroxidase) conjugate 
(1:2500 dilution in 20 mL TBST buffer) for 30 min at room temperature on a rocker.  The 
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membrane was washed again with 3 washes of 25 mL of TBST buffer (10 min per rinse) 
prior to incubation with TMB for signal development.  Typically the membrane was 
incubated with TMB for 5-10 min.  Once bands are visible, the membrane was washed 
with MilliQ water to remove the TMB reagent.    
2.7.14 Fluorescence-based Binding Assay 
 Each protein used in this project, regardless of wild-type or the mutant form, was 
tested for its capability to bind to NBD-PC, the fluorescent analog of PC.  Protein (0.2 
μM) in either SET or TKE buffer was titrated in a 3 mL quartz cuvette with serial 
additions of either 0.5 or 1 μL aliquots of concentrated stocks of NBD-PC prepared in 
ethanol.  The final volume of ethanol was kept below 1 % (v/v) of the total volume.  
After each addition of NBD-PC, the mixture was allowed to equilibrate for 10 min on a 
rotator.  The fluorescence emission was measured between 515 and 550 nm.  The 
excitation wavelength was set at 469 nm.  The maximum fluorescence obtained at 527 
nm for each NBD-PC concentration was then used to plot a one site binding (hyperbola) 
curve using GraphPad Prism.  The equation is as follows: 
Y = Bmax.X / Kd + X  (2) 
With reference to (2), Y = specific binding, Bmax = maximum number of binding sites, 
expressed in the same units as the Y-axis, X = concentration of the ligand and Kd = 
equilibrium dissociation constant, expressed in the same units as the X-axis.  The Kd 
values were used to reflect the binding affinity of each protein for NBD-PC.   
2.7.15 Reduction of NBD-PC by Sodium Hydrosulfite 
 The reduction assay was performed by preparing 2 μM of protein in TKE buffer 
in a 500 μL quartz cuvette.  Following that, the protein solution was incubated with 0.2 
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μM of NBD-PC for 15 min at room temperature on a rotator.  The protein-ligand mixture 
was then titrated with sodium hydrosulfite and the fluorescence was monitored at 532 nm 
over time.  The excitation wavelength was set at 469 nm.  
2.7.16 Concentration Measurement of NBD-PC, Liss Rhod PE and TRITC DHPE 
 Concentrated stocks of NBD-PC were prepared in ethanol.  Each stock 
concentration was determined by measuring the absorbance at 469 nm using a UV 
spectrophotometer.  Using the Beer-Lambert law the concentration of NBD-PC stock 
solutions can be established.  The extinction coefficient for NBD-PC in ethanol is 21000 
cm
-1
M
-1 
as provided by the manufacturer.  Similarly, the concentrations of Liss Rhod PE 
and TRITC DHPE were determined using the same method.  The extinction coefficient of 
Liss Rhod PE and TRITC DHPE are 88000 cm
-1
M
-1
 and 91000 cm
-1
M
-1
 respectively as 
provided by the manufacturer.   
2.7.17 Lipid Vesicle Preparation for FRET Assays 
 Lipid vesicles used for the FRET assay were prepared at a final concentration of 
200 μM.  Generally the vesicles used in the FRET-based transfer assay contained 3 mol% 
FRET acceptor molecules unless stated otherwise.  The FRET quencher used here 
includes either TRITC DHPE or Liss Rhod PE.  The remaining mole fraction consisted of 
PC unless stated otherwise.  Commercial lipid stocks were purchased dissolved in 
chloroform.  Lipid vesicles were prepared in glass vials and dried under nitrogen gas to 
remove chloroform.  Residual chloroform was then further removed by evaporation under 
vacuum for at least 1 h.  The dried lipid mixture was rehydrated with SET or TKE buffer 
and left to sit overnight at 4 °C.  For LUV preparation, rehydrated lipids were subject to 
extrusion using Liposofast-Basic.  Prior to lipid extrusion, lipid mixtures were vortexed 
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thoroughly.  Each lipid mixture was passed through a 100 nm polycarbonate filter at least 
15 times to produce uniform vesicles.  Rehydrated vesicles were stored overnight at 4 °C 
prior to being used and were usually consumed within 3 to 5 days.  SUVs on the other 
hand were prepared by probe sonication.  Rehydrated lipid mixtures were probe sonicated 
on ice for 15 min and stored at 4 °C.  SUVs were consumed within 3 days.     
2.7.18 Lipid Vesicle Preparation for DPI Analysis 
 LUVs (100 nm) for DPI analysis were prepared as described in Section 2.7.17.  
The only exception was that the LUVs were made up of only DOPC, unless stated 
otherwise and the final lipid concentration was 1 mM in DPI buffer.   
2.7.19 Dynamic Light Scattering Analysis of SUV and LUV Sizes  
 Vesicle sizes were determined by dynamic light scattering using Protein Solutions 
DynaPro-99-E.  Measurements were performed at either 25 or 37 °C with a laser power 
of 40-50 %.  The average diameter of LUVs prepared by extrusion using a 100 nm 
polycarbonate filter was ~150 nm with a polydispersity index of 0.15.  The mean 
diameter of SUVs prepared by probe sonication was ~ 29 nm with a polydispersity index 
of 0.12.   
2.7.20 FRET-based Transfer Assay 
 The QuantaMaster-QM-2001-4 fluorometer equipped with a stopped-flow device 
was used to examine the transfer rate of NBD-PC from NBD-PC bound to protein to 
acceptor vesicles.    The excitation wavelength was set at 469 nm while the emission 
wavelength was set at 532 nm.  The FRET assay was performed by incubating 4 μM of 
protein with 0.4 μM of NBD-PC for 15 min at room temperature on a rotator.  The 
protein:ligand ratio was kept at 9:1 to ensure all ligand was bound by the protein.  Using 
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the stopped-flow device the pre-incubated protein-ligand mixture was mixed with 200 
μM acceptor vesicles.  The actual protein, ligand and lipid concentration during 
fluorescence measurement was 2 μM, 0.2 μM and 100 μM respectively.  The acceptor 
vesicles were kept at a 50-fold molar excess, unless stated otherwise, to ensure sufficient 
delivery of the ligand.  The fluorescence decay was monitored over a time frame of 200 
to 360 s.  Typically, 3 replicates were obtained for each assay condition.  The 
fluorescence values were then normalized to the starting fluorescence intensity, which 
corresponds to NBD-PC bound to protein.  The rate of NBD-PC transfer was fit to a two-
phase exponential decay curve using GraphPad Prism.  The fast rate obtained corresponds 
to the ligand transfer rate by PITP.  The equation is as follows: 
Y=Span1.e
-k
1
.X
 + Span2.e
-k
2
.X 
+ Plateau  (3) 
With reference to (3), Y = normalized fluorescence intensity, X = time and k1 and k2 = 
rate constants.  Only the fast rate is considered here. 
2.7.21 FRET-based Pick-up Assay 
 The FRET-based pick-up assay is simply the reverse of the transfer assay.  Here, 
NBD-PC is incorporated into the donor vesicles and the ability of PITP to extract NBD-
PC from the donor vesicles is monitored over time.  Donor vesicles contained 2.5 mol% 
NBD-PC and 2 mol% Liss Rhod PE and the remaining mole fraction consisted of PC. 
The concentration of the donor vesicles was 200 μM while protein concentration was 4 
μM.  However, after mixing protein and lipids together, the final protein and lipid 
concentration was 2 μM and 100 μM respectively.  The increase in NBD-PC fluorescence 
was monitored for 400 s and the assay was performed in duplicates.  Similar to the FRET 
transfer assay, the excitation wavelength was set at 469 nm while the emission 
57 
 
wavelength was set at 532 nm.  The rate at which PITP picked up NBD-PC from lipid 
vesicles was fit to a two-phase exponential association equation using GraphPad Prism.  
The fast rate corresponds to the ligand pick-up rate.  The equation is as follows: 
Y=Ymax1.(1-e
-k
1
.X
) + Ymax2.(1-e
-k
2
.X
) (4) 
where Y = fluorescence intensity, X = time, Ymax1 and Ymax2 = maximum fluorescence 
when the maximum amount of PITP is bound to NBD-PC for the fast and slow rate, k1 
and k2 = rate constants.  Only the fast rate is considered here. 
2.7.22 Tryptophan Fluorescence Quenching Assay 
 The binding affinity of both wild-type PITPα and PITPβ to membranes was 
examined by measuring the quenching of the protein’s tryptophan fluorescence.  0.5 μM 
of protein in TKE buffer was prepared in a 500 μL quartz cuvette.  The protein mixture 
was titrated with serial additions of 100 nm PC LUVs in TKE buffer.  After each addition 
of acceptor vesicles, the reaction mixture was allowed to incubate for 10 min at room 
temperature on a rotator.  The fluorescence emission was measured between 315 and 375 
nm while the excitation wavelength was set at 295 nm.  Alternatively, the tryptophan 
fluorescence quenching assay was performed by titrating 100 nm PC LUVs into a 2 μM 
protein solution with a final volume of 3 mL.  Acceptor vesicles contained 3 mol% of 
pyrene-labeled PE.  The fluorescence emission was measured between 300 and 500 nm 
while the excitation wavelength was set at 295 nm.   
2.7.23 Dual Polarization Interferometry 
 Prior to performing any analysis, the Analight Bio200 was allowed to warm up by 
passing DPI running buffer through the instrument for 1 h.  Following that, the 
instrument was loaded with an unmodified silicon oxynitride sensor chip.  Calibration of 
58 
 
the instrument was then performed with 80 % ethanol and milliQ water.  Once a stable 
baseline was attained, 800 μL samples containing the desired 100 nm LUVs were passed 
over the sensor chip at a flow rate of 25 μL per minute for 8 min.  The lipid layer was 
allowed to adsorb on to the sensor chip until a stable bilayer was formed.  After each lipid 
injection, DPI running buffer was passed over the lipid layer at a flow rate of 50 μL per 
minute for 4 min.  This step was to remove any excess lipid that was deposited on top of 
the lipid layer.  Subsequently, 800 μL of protein sample at the desired concentration was 
passed over the lipid layer at a flow rate of 25 μL per minute for 8 min.  The sensor chip 
was then regenerated with the following washes: 2 % SDS, 80 % ethanol followed by 
milliQ water.   
 The association of protein with the lipid layer on the Analight Bio200 was 
determined by the maximum mass of protein deposited on to the lipid layer.  Typically, 
the mass data from the first 480 s of protein injection was fit to a one-phase exponential 
association model to obtain the maximum mass of protein bound.  The equation is as 
follows: 
Y = Ymax (1 – e
-kt
)  (5) 
With reference to (5), Y = mass of protein bound, Ymax = maximum mass of protein 
bound, t = time, k = rate constant.  To obtain a Kd value of a protein for a given lipid 
composition, the Ymax values for each protein concentration were used to plot a saturation 
binding curve using equation (2).   
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3. RESULTS 
3.1 Protein Expression, Purification and Characterization 
3.1.1 Wild type PITPα and PITPβ 
 PITPα and PITPβ were previously cloned into the pRSETC vector [34] and were 
gifts from our collaborator, Dr. Shamshad Cockcroft, University College London.  The 
pRSETC vector contains an N-terminal His-tag and was expressed in the E. coli strain 
BL21(DE3)pLysS.  His-tagged PITPα was initially purified by means of a nickel affinity 
chromatography using Ni-NTA agarose.  However, the pure protein fractions appeared to 
contain a contaminant of about 20 kDa – see Figure 14.   
 
 
Figure 14: SDS-PAGE analysis of PITPα purification using Ni-NTA column 
Molecular weight marker (1), cell lysate (2), supernatant (3), supernatant flow-through 
(4), wash flow-through (5-7) eluted 3 mL PITPα fraction (8), eluted 2 mL PITPα fraction 
(9) and PITPα in PIPES buffer (10).  
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When Co
2+
-loaded Talon resin was used instead of Ni-NTA agarose, the 
contaminant was successfully removed – Figure 15.  Consequently, Co2+-loaded Talon 
resin was used to purify all the proteins used in this thesis.  The bulk of pure PITPα and 
PITPβ eluted in the first three 1 mL fractions of 150 mM imidazole washes.  The first 3 
fractions were then pooled and subjected to buffer exchange with PIPES buffer using a 
desalting column.  Protein purity was determined by SDS-PAGE and the identity of the 
proteins was confirmed by Western Blot using anti-His antibodies.  See Figures 16 and 
17. 
 
 
Figure 15: SDS-PAGE analysis of PITPα purification using cobalt affinity column 
Molecular weight marker (2), wash flow-through (3) eluted PITPα fraction one to five (4-
8) and PITPα in PIPES buffer (9).   
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Figure 16: SDS-PAGE analysis of PITPβ purification using cobalt affinity column 
Molecular weight marker (1), cell lysate (2), supernatant (3), supernatant flow-through 
(4), wash flow-through (5), eluted PITPβ fraction one to four (6-9), PITPβ in PIPES 
buffer. 
 
 
 
Figure 17: Western blot analysis of PITPα and PITPβ 
PITPα and PITPβ examined by Western blotting using anti-His antibodies. 
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3.1.2 PITPα Mutants: W203A/W204A, K61A and C95A 
 The PITPα mutants created here were previously described in Tilley et al. and 
Shadan et al. [28, 34].  The W203A/W204A mutant no longer has the capacity to bind to 
membranes.  As mentioned previously in Section 1.4.3, both W203 and W204 were 
identified in PITPs to play a role in membrane docking.  Mutation of both tryptophan 
residues to alanine resulted in loss of membrane binding [28].   
 
Figure 18: SDS-PAGE analysis of W203A/W204A purification by cobalt affinity 
column 
Molecular weight marker (1), cell lysate (2), supernatant (3) supernatant flow-through 
(4), wash flow-through (5), eluted W203A/W204A fraction one to four (6-9), 
W203A/W204A in PIPES buffer (10). 
 
K61A is a mutant that is able to bind to PC but whose PI binding is compromised.  
K61A is one of four important residues in the ligand binding pocket that is required for PI 
binding [28].  In contrast, C95A is a mutant that is unable to transfer PC – however, there 
is no data in the literature that shows C95A is not able to bind PC [25, 34].  Since C95A 
is unable to transfer PC, it is assumed that it lacks the capability to bind PC and therefore 
C95 is thought to be important for PC binding.  However, the ability of C95A to bind and 
transfer PI is not compromised.   
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All mutants were successfully created from PITPα plasmid by means of site-
directed mutagenesis as described in Section 2.7.1 using the QuikChange protocol.  The 
sequences of the mutants were confirmed through DNA sequencing (Appendix I).  
Similar to wild type PITPα, all mutant proteins were expressed in E. coli strain 
BL21(DE3)pLysS and purified using Co
2+
-charged Talon resin.  The mutant proteins 
were then characterized by means of SDS-PAGE and Western blot – Figures 18-21.  
 
 
Figure 19: SDS-PAGE analysis of K61A purification by cobalt affinity column. 
Molecular weight marker (1), cell lysate (2), supernatant (3), supernatant flow-through 
(4), wash flow-through (5), eluted K61A fraction one to four (6-9) and K61A in PIPES 
buffer (10).   
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Figure 20: SDS-PAGE analysis of C95A purification by cobalt affinity column. 
Molecular weight marker (1), supernatant (2), supernatant flow-through (3), wash flow-
through (4), eluted C95A fraction one to three (6-9) and C95A in PIPES buffer (10).   
 
 
 
Figure 21: Western Blot analysis of PITPα mutants 
PITPα mutants – K61A, W203A/W204A (A) and C95A (B) – examined by Western 
blotting using anti-His antibodies. 
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3.1.3 RdgBα and Y210A/W211A Mutant.   
 RdgBα and its mutant form, Y210A/W211A, were expressed from the pRSETC 
vector, which was also provided by our collaborator.  The Y210A/W211A is a mutant 
that mimics the W203A/W204A mutant in wild type PITP.  Therefore, it is believed that 
the Y210A/W211A mutant lacks the capacity to bind to lipid membranes.  Similar to the 
other proteins, RdgBα and Y210A/W211A were expressed in E. coli strain 
BL21(DE3)pLysS and purified using Co
2+
-charged Talon resin.  The purity and identity 
of RdgBα and Y210A/W211A were determined by means of SDS-PAGE and Western 
blot respectively – Figures 22-24.   
 
 
Figure 22: SDS-PAGE analysis of RdgBα purification using cobalt affinity column 
Molecular weight marker (1), cell lysate (2), supernatant (3), supernatant flow-through 
(4), wash flow-through (5), eluted RdgBα fraction one to four (6-9) and RdgBα in PIPES 
buffer.   
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Figure 23: SDS-PAGE analysis of Y210A/W211A purification using cobalt affinity 
column 
Cell lysate (1), supernatant (2), supernatant flow-through (3), wash flow-through (4), 
molecular weight marker (5) eluted Y210A/W211A fraction one to four (6-9) and 
Y210A/W211A in PIPES buffer.   
 
 
 
 
Figure 24: Western blot analysis of RdgBα and Y210A/W211A 
RdgBα and Y210A/W211A examined by Western blotting using anti–His antibodies. 
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3.2 Determination of Protein Binding Affinity to NBD-PC 
 In Section 1.7 it was stated that one of the main aims of this thesis is to determine 
the ligand transfer rates of PITPs.  In order to do so, a FRET-based transfer assay was 
employed.  It should be noted that all the transfer assays performed in this thesis was 
conducted with only NBD-PC since it is the only commercially available fluorescent 
ligand of PITP.  Prior to performing the FRET assay, it was crucial to determine the 
binding capacity of PITPs to NBD-PC, the fluorescent analogue of PC.  The binding 
affinity to NBD-PC was determined using a fluorescence binding assay.  NBD-PC was 
obtained commercially from Life Technologies and the structure is shown in Figure 25.  
NBD-labeled lipids are useful tools for studying a variety of processes, which include 
membrane fusion, intracellular lipid transfer and localization of lipids and proteins in 
membranes [68].  The NBD group is sensitive to its environment in that it has only 
marginal fluorescence in a polar environment but fluoresces significantly in a 
hydrophobic environment [68].   
 
Figure 25: Structure of NBD-PC 
 The results from the fluorescence binding assay revealed that the proteins tested 
possessed the capacity to bind NBD-PC – see Table 4.  The Kd values obtained were at 
nanomolar concentrations, which are typical of most biological systems.  A typical 
binding curve is shown in Figure 26 compared with a control assay where no protein was 
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present – Figure 27.  In Table 4 the maximum fluorescence for each protein analyzed is 
also included.  As mentioned above, the NBD group is sensitive to its environment; the 
variation in maximum fluorescence from protein to protein is indicative of the way the 
NBD-PC is bound by each protein.  A lower fluorescence implies that the bound-NBD 
group is more solvent exposed.  This was observed particularly with the following 
proteins: C95A (PITPα), RdgBα, Y210A/W211A and BSA.  BSA was included in the 
analysis as a control protein.  BSA was chosen as a control protein since it is capable of 
binding hydrophobic molecules but lacks the PITP phospholipid binding pocket [69-70].  
 
 Table 4: Affinity of wild type and mutant PITPs, RdgBα, Y210A/W211A and BSA 
to NBD-PC 
The equilibrium dissociation constants of wild type and mutant PITPs, RdgBα, 
Y210A/W211A and BSA to NBD-PC.   Data represents the average of two 
measurements. 
Protein Kd (nM) Maximum Fluorescence (a.u) 
PITPα 104 ± 13 347054 
PITPβ 43 ± 8 89117 
W203A/W204A 67 ± 12 159088 
K61A 19 ± 4 130999 
C95A 17 ± 2 13804 
RdgBα 27 ± 3 8495 
Y210A/W211A 13 ± 17 36815 
BSA 138 ± 19 39029 
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Figure 26: Binding curve of PITPα to NBD-PC 
Binding of PITPα (0.2 μM) to NBD-PC measured by the increase in NBD-PC 
fluorescence.  Data represents the average of two measurements with standard error of 
measurement.   
 
 
Figure 27: No protein control for the fluorescence binding assay 
The fluorescence increase measurement when NBD-PC was added to buffer without the 
presence of proteins.  Data represents the average of two measurements with standard 
error of measurement. 
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3.3 Reduction of NBD-PC by Sodium Dithionite (Na2S2O4) 
 Sodium dithionite has been used as a reducing agent toward NBD.  Specifically, 
dithionite reduces the nitro group in NBD to an amine and as a result NBD fluorescence 
is quenched [71].  In the previous section, it was mentioned that each protein tested in 
this thesis may bind NBD-PC differently.  This was deduced by the variation in 
maximum fluorescence observed for each protein.  To further verify this conclusion a 
dithionite reduction assay was performed.  In this assay, the protein of interest was 
incubated with NBD-PC for 15 min.  NBD fluorescence was then measured up to 500 s 
or until a stabilized fluorescence reading was achieved.  Following that, dithionite was 
added to the pre-incubated protein mixture and fluorescence quenching was followed.  It 
was determined that a minimum dithionite concentration of 4 mM was sufficient to 
generate the quenching of bound NBD-PC – Figure 28.  As a control measure, the same 
volume of buffer was added to the pre-incubated mixture instead of dithionite – Figure 
29.  No change in fluorescence was observed.  This step implies that a small change in 
volume does not affect the fluorescence measurement and therefore the fluorescence 
quenching observed is solely from the reducing ability of dithionite.   
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Figure 28:  Reduction of NBD-PC by sodium dithionite 
2 μM of PITPα was pre-incubated with 0.2 μM of NBD-PC in a total volume of 500 μL 
for 15 min.  NBD-PC fluorescence was measured before and after the addition of 4 mM 
Na2S2O4.   
 
 
Figure 29: Reduction of NBD-PC by sodium dithionite – control experiment 
2 μM of PITPα (orange trace) and PITPβ (yellow trace) was pre-incubated with 0.2 μM 
NBD-PC in a total volume of 500 μL for 15 min.  NBD-PC fluorescence was measured 
before and after the addition of TKE buffer. 
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 The reduction assay was performed with the following proteins: PITPα, PITPβ, 
C95A (PITPα) and RdgBα.  The reduction rates were determined from the fluorescence 
decay curves.  It appears that both PITPα and PITPβ, which had a higher maximum 
fluorescence from the binding assay, had slower reduction rates compared to C95A and 
RdgBα – Table 5.  Since both C95A and RdgBα had the lowest maximum fluorescence 
(Table 4), it is anticipated that both proteins would have a faster reduction rate, which is 
shown here – Table 5. This means that NBD-PC is bound by both C95A and RdgBα in a 
manner whereby the NBD portion is more solvent accessible compared to PITPα.  
Consequently, in the presence of dithionite the more solvent exposed NBD will be 
reduced faster.    
Table 5: Rate constants from NBD-PC reduction by sodium dithionite 
NBD-PC reduction rates by sodium dithionite.  Data represents the average of two 
measurements. 
Protein Rate Constant (s
-1
) 
PITPα 0.0099 ± 0.000009 
PITPβ 0.0073 ± 0.00002 
C95A 0.040 ± 0.0003 
RdgBα 0.036 ± 0.0003 
 
3.4 FRET Transfer Studies 
3.4.1 Characterization of FRET Transfer Assay 
 The FRET transfer assay used in this thesis has been previously described by 
Zhang et al. [72].  The conditions used by Zhang et al. included SET buffer and TRITC 
DHPE as the FRET acceptor molecule.  Here TKE buffer was used instead of SET buffer 
while Liss Rhod PE was used instead of TRITC DHPE.  Prior to data collection, the 
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assay was optimized under these new conditions.  The optimization of the FRET transfer 
assay was performed using PITPβ and lipid vesicles prepared by bath sonication.  Under 
the new conditions, the overall trend observed was similar – Figures 30 and 31.  This 
means that changing the buffer system or the FRET acceptor molecule did not affect the 
outcome of the assay.     
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Figure 30: Comparison between SET and TKE buffer conditions for the FRET 
transfer assay 
Fluorescence loss during ligand transfer by PITPβ (2 μM) in TKE (A) and SET (B) buffer; FRET 
acceptor used was TRITC and lipid vesicles were PC SUVs (100 μM).  A single representative 
data trace is shown.   
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Figure 31: Comparison between TRITC and Liss Rhod PE as FRET acceptor 
molecules in the FRET transfer assay 
Raw fluorescence trace of PITPβ (2 μM) in TKE buffer in the presence of PC SUVs (100 
μM) containing either 3 mol% TRITC (A) or Liss Rhod PE (B).  A single representative 
data trace is shown. 
 
3.4.2 FRET Transfer Studies: Control Experiments 
 Prior to performing the FRET transfer studies a series of control experiments were 
carried out to ensure the validity of the data obtained from the FRET transfer assays.  One 
of the control experiments conducted was to observe what takes place when NBD-PC 
was present in the absence of both protein and lipid vesicles.  It appeared that negligible 
background fluorescence was observed which did not change over time – especially 
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within the time frame of the measurement (Figure 32).  This is consistent with the 
property of NBD, which fluoresces marginally in polar environments [68]. 
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Figure 32: Fluorescence measurement of NBD-PC in TKE buffer  
The fluorescence trace of NBD-PC (0.2 μM) in TKE buffer in the absence of protein and 
lipid vesicles.  A single representative data trace is shown.   
 
 In order to determine the rate of spontaneous transfer of NBD-PC to lipid 
vesicles, PC SUVs were mixed with NBD-PC and the fluorescence of NBD was 
monitored.  The PC SUVs prepared did not contain any FRET acceptor molecules.  It was 
observed that an insignificant increase in NBD fluorescence was seen over time – Figure 
33.  This means that the rate of spontaneous transfer of NBD-PC was negligible in the 
absence of protein.  In contrast a test was conducted to determine the maximum 
fluorescence when the amount of NBD-PC used in the transfer studies were completely 
transferred to lipid vesicles.  This analysis involved preparing PC SUVs containing the 
amount of NBD-PC used in the transfer assays and the NBD fluorescence was measured.  
The results showed that a fluorescence count of approximately 260000 a.u. was observed 
– Figure 34.  In comparison with data from Figure 33 – this observation further verifies 
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that the rate of spontaneous transfer of NBD-PC to lipid vesicles is insignificant 
especially within the time frame of the assay.   
0 100 200 300
0
2000
4000
6000
Time (s)
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
a
.u
)
 
Figure 33: Fluorescence measurement of NBD-PC in the presence of PC SUVs  
The fluorescence trace of NBD-PC (0.2 μM) in the presence of PC SUVs (100 μM) 
without FRET acceptor molecules and protein.  A single representative data trace is 
shown. 
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Figure 34: Fluorescence measurement of NBD-PC incorporated into PC SUVs  
The fluorescence trace of NBD-PC (0.2 μM) incorporated into PC SUVs (100 μM) 
without FRET acceptor molecules.  A single representative data trace is shown. 
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 The final control experiment involved measuring the fluorescence of NBD-PC in 
the presence of protein but in the absence of lipid vesicles.  NBD-PC was incubated with 
the protein of interest for 15 min and the fluorescence of NBD-PC-bound protein was 
determined.  It was noted that a fluorescence count of about 90000 a.u. was obtained.  
Moreover, the fluorescence signal did not vary within the time frame of measurement – 
Figure 35.  This observation also revealed that photobleaching of NBD-PC was not a 
significant problem here.   
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Figure 35: Fluorescence measurement of NBD-PC bound to PITPα without the 
presence of lipid vesicles 
Raw fluorescence trace of NBD-PC (0.2 μM) bound to PITPα (2 μM) in the absence of 
lipid vesicles.  A single representative data trace is shown. 
 
Figure 36 shows a successful transfer assay where pre-incubated NBD-PC bound 
to protein was mixed with lipid vesicles.  The initial fluorescence count is a result of 
NBD-PC bound to protein.  If the transfer of NBD-PC to lipid vesicles is successful, 
quenching of the NBD fluorescence is observed as seen in Figure 36.  The quenching of 
the NBD fluorescence is a result of the presence of a FRET quencher present in the lipid 
vesicles.   
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Figure 36: Fluorescence measurement of NBD-PC bound to PITPα in the presence 
of PC SUVs 
The fluorescence loss of NBD-PC (0.2 μM) bound to PITPα (2μM) in the presence of PC 
SUVs (100 μM).  A single representative data trace is shown. 
 
3.4.3 FRET Transfer Studies with PITPα and PITPβ 
3.4.3.1 The Effect of Membrane Curvature on PITP’s Ligand Transfer Rate 
 The rate of ligand transfer by both PITPα and PITPβ were first measured to PC 
SUVs containing 3 mol% Liss Rhod PE.  Interestingly both PITPα and PITPβ transferred 
NBD-PC to lipid vesicles at significantly different rates.  The results revealed that PITPβ 
deliver NBD-PC to lipid vesicles twice as fast as PITPα – Figure 37.  It should be noted 
that the lipid vesicle concentration used for both PITPα and PITPβ measurements differ; 
100 μM for PITPα and 50 μM for PITPβ.  This is because the ligand transfer rate for 
PITPβ was too fast for complete data-capture using our stopped-flow device.  Therefore, 
with regards to the FRET transfer assays, all PITPβ measurements were performed with 
50 μM lipid concentration instead of 100 μM.  Taking this into consideration, the ligand 
transfer rate of PITPβ is nearly four times faster compared to PITPα.  It is known that 
although both PITPα and PITPβ are structurally similar, their localization within cells and 
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expression in tissues differ.  Thus, it is assumed that both proteins may possess different 
cellular functions.  The variation in the ligand transfer rate observed here between PITPα 
and PITPβ may point towards this direction.   
 When PC SUVs were substituted with PC LUVs, the ligand transfer rate for both 
PITPα and PITPβ decreased significantly – Figure 37.  The ligand transfer rate for PITPβ 
to PC-LUVs dropped by nearly ten-fold when compared to PC SUVs.  However for 
PITPα, no rate constant could be extracted as the ligand transfer rate slowed down 
drastically when PC LUVs replaced PC SUVs.  This observation for both proteins 
implies the preference for highly curved or curvature stressed membrane surfaces during 
ligand transfer.   
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Figure 37: Comparison of ligand transfer rates between PITPα and PITPβ to PC 
vesicles 
Ligand transfer rates for PITPα (2 μM) and PITPβ (2 μM) to PC vesicles.  100 μM lipid 
vesicles were used for PITPα and 50 μM for PITPβ.  Data are of the average of six 
measurements with standard error of measurement. (* denotes unpaired t-test, p ˂ 
0.0001).  
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3.4.3.2 The Effect of PI on PITP’s Ligand Transfer Rate 
 It is known that both PITPα and PITPβ possess a higher affinity for PI compared 
to PC [20].  Based on this observation, it is thought that the presence of PI in lipid 
membranes may increase the ligand transfer rate of PITP.  However when PI was present 
in lipid vesicles, the ligand transfer rate for PITPβ did not change significantly compared 
to when no PI was present – Figure 38.  In the case of PITPα, there was a slight increase 
in the transfer rate when 4 mol% PI was present in lipid vesicles.  However, when the PI 
content in lipid vesicles were increased from 4 to 16 mol%, the increase in transfer rate 
actually diminished by ~30 % – Figure 38.   
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Figure 38: The effect of PI on the ligand transfer rates of PITPs 
Ligand transfer rates for PITPα (2 μM) and PITPβ (2 μM) to PC SUVs containing PI.  
100 μM lipid vesicles were used for PITPα and 50 μM for PITPβ.  Data are the average 
of six measurements with standard error of measurement.  Data for PITPα were 
significantly different between 0 and 4 % PI (unpaired t-test, p = 0.0031) and between 4 
and 16 % PI (unpaired t-test, p = 0.0314).  Data for PITPβ were not significantly 
different. 
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3.4.3.3 The Effect of PS on PITP’s Ligand Transfer Rate 
 An alternative anionic lipid was tested to determine if charge played a role in the 
ligand transfer rate of PITP.  In this case, PS was used instead of PI.  The results showed 
that the transfer rate increased for PITPβ when 4 mol% PS was present in lipid vesicles 
but no further increase in transfer rate was observed when the PS content was increased 
to 16 mol% - Figure 39.  In contrast, PITPα showed gradual increase in transfer rate as 
the PS concentration increased from 0 to 16 mol% in lipid vesicles – Figure 39.   
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Figure 39: The effect of PS on the ligand transfer rates of PITPs 
Ligand transfer rates for PITPα (2 μM) and PITPβ (2 μM) to PC SUVs containing PS.  
100 μM lipid vesicles were used for PITPα and 50 μM for PITPβ.  Data are averages of 
three to six measurements with standard error of measurement.  Data for PITPα were 
significantly different (unpaired, t-test, p ˂ 0.05).  Only data for PITPβ between 0 and 4 
% PS were significantly different (unpaired t-test, p = 0.014).   
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3.4.3.4 The Effect of PA on PITP’s Ligand Transfer Rate 
 The presence of PA in lipid vesicles was also tested to establish whether PA 
played a role on the ligand transfer rate of PITPs.  Besides being an anionic lipid, PA has 
recently been shown to play a plausible role in recruiting Nir2 to membranes [73].  Nir2 
or RdgB α1 is a human Class II PITP – see Section 1.4.1.  PA is an indirect product of 
PI(4,5)P2 hydrolysis at the plasma membrane.  The two main products of PI(4,5)P2 
hydrolysis are inositol 1,4,5-triphosphate and DAG, both which are signaling molecules 
[74].  DAG in turn can be phosphorylated to produce PA.  In order to maintain the 
signaling cascade at the plasma membrane, PI(4,5)P2 needs to be replenished by 
supplying PI to the plasma membrane.  At the same time, the accumulated PA at the 
plasma membrane needs to be transferred to the ER for conversion to PI [74].  In the 
study conducted by Kim et al. it was shown that Nir2 could bind PA at the plasma 
membrane and in turn deliver PI from the Golgi apparatus.  Based on the PA-binding 
capacity and PI-transfer ability of Nir2, it was proposed that Nir2 may play a role in 
coupling PA to phosphoinositide signaling [73-74].   
 Despite PI(4,5)P2 existing predominantly in the plasma membrane, PI(4,5)P2 may 
be present in the Golgi apparatus transiently [75].  Therefore, the effect of PA was tested 
on the ligand transfer rate of both PITPα and PITPβ.  The results showed that the 
presence of PA in lipid vesicles significantly increased the ligand transfer rate of PITPα 
and PITPβ – Figure 40.  
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Figure 40: The effect of PA on the ligand transfer rates of PITPs to lipid vesicles 
Ligand transfer rates for PITPα (2 μM) and PITPβ (2 μM) to PC SUVs containing PA.  
100 μM lipid vesicles were used for PITPα and 25 μM for PITPβ.  Data are averages of 
three measurements with standard error of measurement.  (* denotes unpaired t-test, p ˂ 
0.0001; ** denotes p ˂ 0.05) 
 
3.4.3.5 The Effect of Phosphoinositides on PITP’s Ligand Transfer Rate 
 PI delivery to membranes by PITPs has been shown to be associated with the 
production of phosphoinositides.  Therefore, whether the presence of phosphoinositides 
in membranes played a role in PITP ligand transfer was examined.  PITPα is localized 
mainly in the nucleus and cytoplasm [25].  PI(4,5)P2 is the dominant phosphoinositide 
present in the nucleus.  However, PI(3,4,5)P3 is also thought to be present in the nucleus 
but in smaller quantities [7, 9].  For this reason the presence of both PI(4,5)P2 and 
PI(3,4,5)P3 in membranes was investigated to determine if these phosphoinositides have 
an effect on the ligand transfer rate of PITPα.  The results obtained reveal that the transfer 
rate decreased by nearly half when 2 mol% PI(4,5)P2 was present in lipid vesicles as 
opposed to when no PI(4,5)P2 was present – Figure 41.  Further increasing the 
concentration of PI(4,5)P2 in lipid vesicles to 4 mol% did not decrease the ligand transfer 
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rate of PITPα.  A similar trend was observed when PI(3,4,5)P3 was present instead – 
Figure 41.   
 In contrast to PITPα, PITPβ is mainly localized in the ER and Golgi apparatus 
[25].  The main phosphoinositide present in Golgi apparatus is PI4P [7].  Therefore the 
effect of the presence of PI4P in lipid vesicles on PITPβ’s ligand transfer rate was also 
investigated.  It appears that the presence of 2 mol% PI4P in lipid vesicles reduces the 
ligand transfer rate of PITPβ – Figure 42.  Further increasing the concentration of PI4P 
to 4 mol% did not decrease the ligand transfer rate.   
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Figure 41: The effect of PI(4,5)P2 and PI(3,4,5)P3 on the ligand transfer rate of 
PITPα to lipid vesicles 
Ligand transfer rates of PITPα (2 μM) to lipid vesicles (100 μM) containing either 
PI(4,5)P2 or PI(3,4,5)P3.  Data are averages of three to six measurements with standard 
error measurement. (* denotes unpaired t-test, p ˂ 0.05) 
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Figure 42: The effect of PI4P on the ligand transfer rate of PITPβ to lipid vesicles 
Ligand transfer rates of PITPβ (2 μM) to lipid vesicles (50 μM) containing PI4P.  Data 
are averages of three to six measurements with standard error measurement. (* denotes 
unpaired t-test, p ˂ 0.001) 
 
3.4.4 FRET Transfer Studies with W203A/W204A, K61A and C95A 
 The ligand transfer rate for the PITPα mutants namely W203A/W204A, K61A 
and C95A were also determined.  For all three proteins, the transfer rate was measured 
with only PC SUVs.  It is clear that both W203A/W204A and C95A were unable to 
transfer NBD-PC to lipid vesicles – Figure 43.  No rate constant could be extracted; 
therefore, the raw data for both W203A/W204A and C95A are shown instead.  The 
results observed for W203A/W204A were anticipated since the capacity of this mutant to 
bind to membranes had been compromised.  Likewise the results for C95A were also 
expected since it was previously shown that C95A lacks the capability to transfer PC [23, 
36].  Since K61A is still able to transfer PC but not PI it is no surprise that the ligand 
transfer rate of K61A with NBD-PC were closely related to those seen with wild type 
PITPα (Figure 44).   
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Figure 43:  Ligand transfer for W203A/W204A and C95A to PC SUVs  
The fluorescence loss during ligand transfer by W203A/W204A (2 μM) [A] and C95A (2 
μM) [B] to PC SUVs (100 μM).  A single representative data trace is shown.   
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Figure 44: Comparison of ligand transfer rates between PITPα and K61A to PC 
SUVs 
Ligand transfer rates of PITPα (2 μM) and K61A (2 μM) to PC SUVs (100 μM).  Data 
are averages of three to six measurements with standard error measurement.   
 
3.4.5 FRET Transfer Studies with RdgBα and Y210A/W211A 
 
 FRET transfer studies with RdgBα revealed that the protein was unable to transfer 
NBD-PC to PC lipid vesicles – Figure 45.  It should be noted that for all previous 
transfer assays, the protein concentration was set at 2 μM.  However, due to the poor 
expression of RdgBα a protein concentration of 1 μM was used instead.  The transfer data 
for RdgBα is not surprising since despite having a high affinity for NBD-PC, Kd of 27 ± 3 
nM, the maximum fluorescence obtained was low (8495 a.u.) compared to wild type 
PITPα (347054 a.u.).  A similar trend was observed for the PITPα mutant, C95A, which 
showed a high affinity for NBD-PC (Kd = 17 ± 2 nM) but a low maximum fluorescence 
(13804 a.u.) and the inability to transfer NBD-PC to lipid vesicles.  It can, therefore, be 
deduced that both RdgBα and C95A bind NBD-PC differently than wild type PITPα and 
in a manner where the NBD group is more solvent exposed, which explains the lower 
maximum fluorescence.  Moreover, the NBD reduction assay by sodium dithionite 
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revealed that NBD-PC bound to either RdgBα or C95A had a faster reduction rate, by 
nearly four times compared to wild type PITPα.  This assay verifies the binding variation 
of NBD-PC by RdgBα and C95A compared to wild-type PITPα.  Taking into 
consideration the data at hand, it can be inferred that both RdgBα and C95A binds NBD-
PC differently from wild type PITPα and in a manner that makes both proteins poor 
transporters of NBD-PC to lipid vesicles.  The RdgBα data obtained here are in 
agreement with a recent study conducted by Yadav et al. [76].  The authors demonstrated 
that the PITP domain of RdgBα was a poor binder and transporter of PC [76].   
 In contrast, the mutant form of RdgBα, Y210A/W211A, which is supposed to 
lack membrane binding capabilities, was able to transfer NBD-PC to PC lipid vesicles but 
at a low rate, k = 0.04 ± 0.01 s
-1
, as determined from two measurements.  The 
Y210A/W211A mutant was designed to mimic the PITPα mutant, W203A/W204A, 
which also lacks the capacity to bind to membranes.  While W203A/W204A showed the 
inability to transfer NBD-PC to lipid vesicles, Y210A/W211A did.  However, the transfer 
rate was slower by 12 times compared to wild type PITPα, which had an average transfer 
rate of 0.48 ± 0.05 s
-1.  The RdgBα protein is a multi-domain protein unlike wild type 
PITPα.  However, in these studies only the PITP domain of RdgBα is expressed and used 
for our investigation.  The PITP domain of RdgBα shares only 40 % sequence identity 
with wild type PITPα [47].  Therefore, the behavior of the PITP domain of RdgBα may 
not necessarily be similar to that of wild type PITPα.  In other words, the Y210 and 
W211 residues in RdgBα may not be essential for membrane docking as those of W203 
and W204 in PITPα.  In addition, RdgBα already possesses domains that help with 
membrane interactions [44].   
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Figure 45: Ligand transfer by RdgBα to PC SUVs 
Fluorescence loss during ligand transfer by RdgBα (1 μM) to PC SUVs (100 μM).  A 
single representative data trace is shown. 
 
3.5 FRET Pick-up Studies 
3.5.1 FRET Pick-up Studies: Control Experiments 
 The FRET pick-up assay is the reverse of the FRET transfer assay and it simply 
measures the ability of PITPs to pick up NBD-PC from lipid vesicles.  In this assay, 
NBD-PC is incorporated into SUVs along with Liss Rhod PE and PC.  This means that 
the fluorescence of NBD-PC in the lipid vesicles is quenched by the presence of Liss 
Rhod PE.  When these lipid vesicles containing NBD-PC is mixed with PITP, the 
fluorescence of NBD-PC was followed.  An increase in NBD-PC fluorescence implies 
that PITP has successfully picked up NBD-PC from the lipid vesicles. A typical curve 
depicting this phenomenon is shown in Figure 46A. Alternatively, the fluorescence of 
Liss Rhod PE can also be monitored instead.  In this case, a fluorescence decrease is 
observed as shown in Figure 46B.  However for the purpose of consistency, the 
fluorescence of NBD-PC will be reported here.   
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Figure 46: FRET pick-up assay monitored by NBD-PC fluorescence increase (A) 
and Liss Rhod PE fluorescence quenching (B) 
The fluorescence trace of NBD-PC (A) and Liss Rhod PE (B) during ligand extraction by 
PITPα (2 μM) from PC SUVs (100 μM).  A single representative data trace is shown. 
 
When no protein was present, no increase in NBD-PC fluorescence was observed 
as shown in Figure 47A.  A control protein, BSA, was also examined in this study.  It 
appears that no increase in NBD-PC fluorescence was observed when BSA was present 
instead of PITP – Figure 47B.  This suggested that BSA was not able to pick up NBD-
PC from lipid vesicles.  In addition this result further verified that the increase in NBD-
PC fluorescence observed in the presence of PITP was attributed to the capacity of PITP 
to pick up NBD-PC from membranes.   
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Figure 47: FRET pick-up assay control experiments with no protein (A) and with 
BSA (B) 
The fluorescence trace of NBD-PC in the absence of PITP (A) and in the presence of 
BSA (B) in the FRET pick-up assay.  A single representative data trace is shown. 
 
3.5.2 FRET Pick-up Studies with PITPα and PITPβ 
 Both PITPα and PITPβ showed the ability to pick up NBD-PC from lipid vesicles 
as shown in Figure 48.  From the results shown, it appears that PITPβ can pick up NBD-
PC faster than PITPα.  This is in line with the observation from the FRET transfer assay 
where PITPβ had a faster ligand transfer rate compared to PITPα.   
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Figure 48: FRET pick-up studies with PITPα and PITPβ 
Ligand pick-up rates of PITPα (2 μM) and PITPβ (2 μM) from PC SUVs (100 μM).  Data 
are averages of two measurements with standard error measurement. 
 
3.6 Investigation of Protein-Membrane Interactions by DPI 
3.6.1 The Interaction of PITP with DOPC Lipid Layer 
 The capacity of PITP to bind to membranes was analyzed by means of DPI.  In 
this assay, planar immobilized lipid bilayers are utilized instead of lipid vesicles.  The 
immobilized lipid layer is formed when 100 nm vesicles were adsorbed and ruptured onto 
the DPI sensor chip surface.  Once a stable lipid layer is achieved, protein was introduced 
over the immobilized lipid layer and the protein mass adsorbed onto the lipid layer was 
recorded.  The same procedure was repeated with different protein concentrations, which 
allow protein binding affinity to be determined.   
 Using this methodology, both PITPα and PITPβ showed the capacity to bind 
DOPC lipid layers with a Kd of 1.85 ± 0.47 μM and 0.81 ± 0.45 μM respectively – 
Figures 49 and 50.  The Bmax values for both PITPα and PITPβ are as follows: 0.53 ± 
0.06 ng/mm
2
 and 0.42 ± 0.09 ng/mm
2.  Interestingly, PITPβ appeared to have a higher 
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affinity by nearly two-fold for DOPC lipid layers compared to PITPα despite having 
closely related Bmax values.  However, in comparison to previous proteins analyzed by 
DPI, the amount of PITP bound to the lipid layer in general appeared to be low.  
Tocopherol transfer protein (TTP) for example, showed a Kd of 1.64 ± 0.32 μM and a 
Bmax value of 2.09 ± 0.23 ng/mm
2
 for DOPC:DOPS (90:10) lipid layers [77].  Note that 
although the Kd was comparable to that of PITPα, the Bmax for TTP was significantly 
higher which indicates more protein was bound to the lipid surface.   
 The binding of W203A/W204A mutant to DOPC lipid layers was also examined 
by DPI.  However, no binding was observed (data not shown).  This was anticipated since 
the W203A/W204A mutant is known to be unable to bind to membranes [30, 36]. 
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Figure 49: Plot of maximum specific mass of PITPα bound to DOPC lipid layer 
Final lipid concentration was 1 mM.  Data are averages of two measurements with 
standard error of measurement. 
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Figure 50: Plot of maximum specific mass of PITPβ bound to DOPC lipid layer 
Final lipid concentration was 1 mM.  Data are averages of two measurements with 
standard error of measurement. 
 
3.6.2 The Effect of PI on PITP Binding to Lipid Membranes 
 To determine whether PI played a role in PITP binding to membranes, PI was 
incorporated into the immobilized lipid layers.  The protein concentration was fixed at 0.5 
μM and the amount of mass adsorbed to the lipid layers with increasing PI concentration 
was monitored.  As seen in Figure 51 the results obtained did not show that PI had a 
significant effect on PITP binding to membranes.  This was true for both PITPα and 
PITPβ. 
3.6.3 The Effect of PS on PITP Binding to Lipid Membranes 
 The effect of PS on PITP binding to membranes was also determined by DPI.  
Similar to PI, no significant enhancement or diminishment of PITP binding to 
membranes was observed in the presence of PS – see Figure 52.   
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Figure 51: The effect of PI on PITP binding to membranes 
The maximum specific mass of PITPα and PITPβ at 0.5 μM to DOPC lipid layers (1 
mM) containing PI.  Data are averages of two to four measurements with standard error 
of measurement.   
 
 
0 4 10 16
0.0
0.1
0.2
0.3
0.4
PITP
PITP
PS Content (mol %)
M
a
x
im
u
m
 M
a
s
s
 (
n
g
/m
m
2
)
 
Figure 52: The effect of PS on PITP binding to membranes 
The maximum specific mass of PITPα and PITPβ at 0.5 μM bound to DOPC lipid layers 
(1 mM) containing PS.  Data are averages of two measurements with standard error of 
measurement. 
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3.6.4 The Effect of PE on PITP Binding to Lipid Membranes 
  PE is a negative curvature inducing lipid [78] and the effect of PE on PITP 
binding to membranes was examined.  Although in DPI analysis the lipid layers are 
expected to be planar, incorporation of curvature inducing lipids such as PE is thought to 
increase the curvature stress within the planar lipid layer.  In other words, forcing a lipid 
that naturally wants to curve into a flat configuration may result in a bilayer that is 
suffering some physical packing stress.  Since in the FRET transfer studies it was 
observed that PITP had a preference for curved membrane surfaces – it is thought that the 
same effect on PITP binding to membranes may be seen here.  To test this hypothesis a 
concentration of up to 25 mol% PE was incorporated into the DOPC lipid layer.  
However, the results showed that the presence of PE did not significantly enhance PITP 
binding to membranes – Figure 53.  Comparing the maximum mass of PITPs to just 
plain DOPC lipid layers versus DOPC lipid layers containing PE – there was no 
significant difference.   
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Figure 53: The effect of PE on PITP binding to membranes 
The maximum specific mass of PITPα and PITPβ at 0.5 μM bound to DOPC lipid layers 
(1 mM) containing PE.  Data are averages of two measurements with standard error of 
measurement. 
 
3.6.5 The Effect of Ligand-bound PITP on PITP Binding to Membranes 
  Both PITPα and PITPβ at 0.5 μM were pre-incubated with either PI or PC for one 
hour.  The pre-incubated PITPs were then introduced over a DOPC lipid layer to 
determine the amount of PITPs bound to membranes.  The purpose of this investigation 
was to determine the amount of PITPs bound to membranes in its ligand-bound form.  In 
comparison to ligand-free PITPα, the presence of PC did not significantly change the 
amount of PITPα bound to membranes – Figure 54.  A similar trend was observed for 
PITPβ with PC – Figure 54.  However when PI was pre-incubated with either PITPα or 
PITPβ nearly ~70 % less PITPα was found to bind to membranes and no binding was 
observed for PITPβ – Figure 54.  The data obtained here revealed that PI-bound PITPs 
showed much reduced membrane affinity.  
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Figure 54: Comparison of maximum specific mass of PITPs bound to DOPC lipid 
layers with no ligand, bound PC and bound PI 
Protein concentration was at 0.5 μM and DOPC concentration was at 1 mM.  Data are 
averages of two to four measurements with standard error of measurement.  Arrow 
indicates no mass data obtained for PITPβ pre-incubated with PI. (* denotes unpaired t-
test, p = 0.0099) 
 
3.6.6. The Interaction of RdgBα and Y210A/W211A with Lipid Membranes 
 The amount of RdgBα at 0.5 μM bound to membranes was also determined by 
DPI analysis.  Three different membrane systems were tested which include DOPC, 
DOPC containing 10 mol% PI and PS respectively.  The results obtained revealed no 
significant difference between the amounts of RdgBα bound to the different membrane 
systems – Figure 55.  Thus, the presence of either PI or PS did not substantially affect 
RdgBα binding to membranes.  Moreover, there was also no significant difference 
between the amounts of RdgBα bound to DOPC lipid layers in comparison to wild type 
PITPα.  The same amount bound to DOPC lipid layers was observed for the RdgBα 
mutant, Y210A/W211A (YW/AA) mutant – Figure 55.   
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Figure 55: Comparison of maximum specific mass of RdgBα, YW/AA and PITPα 
bound to lipid membranes   
Protein concentration was at 0.5 μM and lipid concentration was at 1 mM.  Data are 
averages of two measurements with standard error of measurement. 
 
3.7 PITP Interaction with Membranes Analyzed through Tryptophan Fluorescence 
Quenching 
 
 The interaction of both PITPα and PITPβ to membranes was analyzed using a 
tryptophan fluorescence quenching assay.  The purpose of this assay was to utilize an 
alternative but comparative method to measure the membrane binding affinity of PITPs.  
PITPs possess seven tryptophan residues and two of the seven tryptophan residues are 
directly involved in membrane interactions.  Tryptophan fluorescence quenching assays 
have been used to examine protein-lipid interactions [79].  Therefore, an attempt was 
made to measure the protein-lipid interactions of PITPs using this assay.  Initially the 
assay was performed by measuring the fluorescence quenching of tryptophan residues 
present in PITPs.  However, no fluorescence quenching was observed upon addition of 
PC lipid vesicles.  The assay was then modified with the incorporation of pyrene-labeled 
PE into the lipid vesicles at 3 mol%.  Here, the fluorescence of pyrene-PE was measured 
between 300 – 500 nm.  However, no change in fluorescence was observed.   
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4. DISCUSSION & CONCLUSION 
4.1 Ligand Transfer and Pick-up by PITPs 
 The purpose of performing the FRET transfer and pick-up assay was to show the 
capacity of PITPs to deliver and extract NBD-PC from membranes, and in each case both 
assays proved that the proteins can act as lipid transfer catalysts.  This is an essential 
function to know since PITPs are believed to be lipid transfer proteins.  Furthermore, the 
FRET assays employed here have also been used to measure the rate of ligand delivery 
and pick-up by PITPs.  This enables the comparison of rates to different membrane 
systems, especially using the FRET transfer assay.   
 One of the most interesting observations was the difference in ligand transfer rate 
between PITPα and PITPβ to PC SUVs.  It appears that PITPβ has a four-fold faster 
ligand transfer rate compared to PITPα despite their overall similarity in structure.  The 
difference in the ligand transfer rates between PITPα and PITPβ correlates with studies 
previously conducted by Shadan et al. [36].  In Shadan’s investigation, it was shown that 
PITPβ had a higher propensity for membrane binding compared to PITPα.  Their results 
revealed that PITPβ contacted membranes more frequently and within a shorter time 
frame compared to PITPα [36] – see Section 1.4.5 for further details.  The faster ligand 
delivery rate of PITPβ could mean that PITPβ is interacting with membranes more 
quickly and frequently compared to PITPα and consequently gives up its ligand more 
easily.  In support of PITPβ’s faster ligand delivery rate, the FRET pick-up studies 
revealed that PITPβ also had a faster ligand pick-up rate compared to PITPα emphasizing 
PITPβ’s greater efficiency at interacting with membrane bilayers. 
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 Another interesting observation is that both PITPα and PITPβ appeared to have a 
preference to deliver their ligands to highly curved membranes.  The ligand transfer rate 
for PITPα and PITPβ were significantly higher when SUVs were the accepting 
membranes versus LUVs. SUVs were prepared by means of probe sonication and were 
estimated to have an average diameter of 30 nm.  LUVs on the other hand were prepared 
by extrusion using a 100 nm filter membrane and the average diameter of the LUVs used 
were determined to be about 150 nm.  The lipid head-groups of the outer bilayer in SUVs 
are less densely packed together compared to LUVs [80-81].  The spaces between the 
lipid head groups allow easier access for PITPs to insert into the head group region of 
SUVs compared to LUVs.  This could possibly explain the faster ligand transfer rate of 
PITPs to SUVs versus LUVs.  PITPs could take a longer time or have less favorable 
interaction energy to access the densely packed lipid head groups in LUVs, which would 
explain the slower ligand transfer rate.  The propensity for highly curved membranes is a 
phenomenon that is beginning to be more commonly seen with LTPs [14].  Other 
examples include TTP [72] and the fatty acid binding protein (FABP) [82] – both 
proteins showed higher ligand transfer rates to SUVs compared to LUVs.   
 The relevance of this observation in biological systems can be described as 
follows.  Biological membranes undergo constant remodeling mainly to accommodate 
cellular events such as cell division and cellular trafficking [60].  These events 
consequently result in localized areas of membrane curvature.  The change in membrane 
curvature is mainly brought about by proteins and lipids as discussed in Section 1.6.3.  It 
is plausible that LTPs have been designed to take advantage of these localized areas of 
membrane curvature to bind to membranes and deliver or extract its ligands.  Therefore, 
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it is likely that PITPs interact with membranes by sensing the physical changes in 
membranes which is becoming a more common mechanism for the recruitment of 
peripheral proteins to membranes [49-51].    
Synaptojanin 1 (SYNJ1), although a non-LTP, is an example of a protein where 
both its recruitment to membranes and activity is sensitive to membrane curvature.  
SYNJ1 is a phosphoinositide phosphatase which converts PI(4,5)P2 to PI4P [83].  SYNJ1 
is highly expressed in nerve terminals and is found to play a role in clathrin-mediated 
endocytosis [83].  Using a sedimentation assay, Chang-Ileto et al. showed that the 
binding of SYNJ1 to 50 nm liposomes increased by nearly 50 % compared to 800 nm 
liposomes.  Furthermore, the hydrolysis of PI(4,5)P2 by SYNJ1 was markedly increase in 
the presence of 50 nm liposomes in comparison to 800 nm liposomes by approximately 
30 % [83]. 
 In the next study I investigated whether the presence of PI in membranes played a 
role in the ligand transfer rate of PITP.  While PI did not affect the ligand transfer rate of 
PITPβ, only 4 mol% of PI in membranes increased the ligand transfer rate of PITPα 
(Figure 38).  However, the ligand transfer rate of PITPα did not show a dramatic increase 
even with 4 mol% PI.   Moreover, when the PI concentration was further increased to 16 
mol%, the increase in ligand delivery was diminished.  Overall it seems that the 
occurrence of PI in a bilayer does not have a significant effect on the rate of the ligand 
transfer mechanism of PITPs.  It was hypothesized that due to the higher affinity of 
PITPs for PI, the presence of PI in membranes may attract PITPs to membranes to 
deposit the NBD-PC for which it has less affinity, and withdraw PI for transfer to its 
required destination.  However, the results observed here do not support this hypothesis.   
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 Since PI is an anionic lipid, an alternative anionic lipid was also tested to 
determine if charge played a role in the ligand transfer of PITPs.  Here, PS was used 
instead of PI.  The ligand transfer rate for PITPα increased as the concentration of PS in 
lipid vesicles increased (Figure 39).  However for PITPβ, the ligand transfer rate only 
increased at 4 mol% PS.  A further increase in PS concentration to 16 mol% did not 
change the ligand transfer rate of PITPβ.  At this point it is inconclusive whether charge 
plays a role here especially for PITPα.  Taking into consideration other LTPs whose 
ligand transfer and membrane interaction is influenced by anionic lipids, the effect is 
much more significant than what was observed with PITPα.  One such example is FABP 
which showed up to nearly 20-fold increase in transfer rate when anionic lipids 
(depending on lipid species) were present in the acceptor membrane [82].   
Taking into consideration the data obtained for both PI and PS in regards to 
PITPβ, it can be deduced that charge likely has no role in membrane recognition by the 
protein.  In contrast, ligand transfer by PITPα in the presence of PS increased to only a 
minor extent, and no change was observed for PI.  However, the rate enhancement effect 
of PS is not nearly as drastic as seen for FABP.  Therefore, it is unlikely that charge 
affects the ligand transfer rate of PITPα.  Moreover, if both PS and PI are negatively 
charged lipids – it is unclear why PS would have an effect on the ligand transfer rate of 
PITPα and not PI.  Since both PI and PS possess a similar shape whereby both lipids are 
cylindrical [84-85], it is unlikely that membrane curvature brought about by these lipids 
is causing the different effects in the ligand transfer rate of PITPα.  However, PI and PS 
may affect other physical parameters of membranes such as lipid packing.  The effect of 
PI in PC model membranes has been previously examined and PI has been found to affect 
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the lipid packing [86].  This may provide an explanation for the different effects of PI and 
PS on the transfer rates of PITPα.  However, if this is true, it remains unclear why PS did 
not have the same effect on PITPβ since both PITPα and PITPβ are closely related.  
There is a possibility that even though both PITPα and PITPβ are structurally similar they 
may differ in their ligand transfer mechanism.  This hypothesis requires further 
investigation.   
 PA is also an anionic lipid and we tested the effect of PA on PITP ligand transfer 
due to the known effect it has in recruiting Nir2 proteins to membranes.  The data 
obtained for both PITPα and PITPβ showed that PA significantly increased the ligand 
transfer rates by approximately two-fold when 16 mol% PA was present in membranes 
(Figure 40).  Both PITPα and PITPβ have been shown not to bind PA directly [41, 87].  
In the case of the Nir2 proteins, it has been shown that Nir2 binds PA and it is believed 
that the capability of Nir2 to bind PA, and at the same time deliver PI, is what associates 
Nir2 with phosphoinositide signaling [73-74].  However, with the PITP proteins, this is 
not the case.  Besides being an anionic lipid, PA is also a negative-curvature inducing 
lipid [88-90].  Since PITPs do not bind PA, it is unlikely that the enhanced ligand transfer 
rate observed for PITPα and PITPβ is due to their capacity to specifically recognize and 
bind PA in membranes, but rather, to recognize the physical effect that PA has on 
membranes. 
 The effect of phosphoinositides in membranes on the ligand transfer rate of PITPs 
was also examined.  It was interesting to note that the presence of 2 mol% of both 
PI(4,5)P2 and PI(3,4,5)P3 decreased the ligand transfer rate of PITPα by nearly half 
(Figure 41).  However, increasing the phosphoinositide concentration did not further 
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diminish the ligand transfer rate.  To date there is no evidence showing that PITPs 
possesses the ability to bind or recognize phosphoinositides.  Therefore, this would be an 
area of interest to pursue further based on the data obtained here.  Similarly, PITPβ 
showed the same trend when PI4P was present in membranes; the ligand transfer rate of 
PITPβ decreased by half at 2 mol% of PI4P (Figure 42).  Doubling the PI4P 
concentration to 4 mol% did not further decrease the ligand transfer rate of PITPβ.  This 
most likely has to do with the phosphoinositides effect on membrane properties such as 
membrane curvature, which is brought about by the larger head groups of 
phosphoinositides [91-92].   
 At this point it is still uncertain whether PITPs can bind phosphoinositides 
directly.  If PITPs binds phosphoinositides as a ligand, then the presence of 
phosphoinositides in membranes should increase rather than decrease the ligand transfer 
rate of PITPs.  Phosphoinositides are highly negatively charged lipids – they carry more 
than one negative charge unlike PI, PS and PA, which have only one negative charge 
[93].  The inner leaflet of the plasma membrane contains a high amount of anionic lipids 
that act as recruiting agents of peripheral membranes by means of electrostatic 
interactions [94].  However, with the PITPs, the reverse is seen whereby the ligand 
transfer rate of PITPs is reduced by phosphoinositides.  The possibility of charge 
repulsion involved here should not be dismissed.  To address this hypothesis the 
electrostatic potential map for PITPα and PITPβ was examined – Figure 56.  The 
majority of the negative electrostatic potential (red) of both PITPs is located away from 
the two tryptophan residues which are essential for membrane docking.  Therefore, it is 
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unlikely that charge repulsion accounts for the diminished ligand transfer rate observed 
for PITPs when phosphoinositides are present in membranes. 
Phosphoinositides have been shown to affect the physical properties of 
membranes including membrane curvature and elasticity [92]. These physical changes to 
the lipid bilayer may in turn affect protein function.  These physical changes to the lipid 
bilayer can be brought about by either the depletion or enrichment of phosphoinositides.  
As mentioned previously, phosphoinositides have larger head groups, which mean they 
are positive-curvature inducing lipids [91-92].  Our data have demonstrated that PITPs 
prefer to bind to membranes where the head groups are loosely packed.  We have 
observed higher ligand transfer rates with PC SUVs versus LUVs and also with PC SUVs 
containing PA, which is a negative-curvature inducing lipid.  Therefore, it can be 
deduced that the decreased ligand transfer rate to SUVs containing phosphoinositides 
may be due to the lack of head group space for PITPs to insert its tryptophan residues.  
To test this deduction further, the ligand transfer rate of PITPs to SUVs can be examined 
with the presence of an alternative lipid with a large head group such as 
lysophosphatidylcholine [56].   
The ability of PITPs to recognize the presence of phosphoinositides in membranes 
should also not be disregarded.  If PITPs truly acts as LTPs and deliver PI for the 
biosynthesis of membrane phosphoinositides, there is a possibility that phosphoinositides 
could act as a negative feedback for PITPs to stop or reduce PI delivery.  However, this 
hypothesis needs to be further established by first examining whether PITPs recognizes 
and binds phosphoinositides as a ligand.   
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Figure 56: Electrostatic potential map of PITPα (A) and PITPβ (B) 
The electrostatic potential map of PITPα (PDB code: 1UW5) and PITPβ (PDB code: 
1T27) presented by DeepView.  Areas of positive electrostatic potential are represented 
in blue and negative electrostatic potential is represented in red.  Tryptophan residues are 
highlighted in blue for PITPα and white for PITPβ. 
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4.2 PITP’s Membrane Interactions 
 DPI analysis revealed that both PITPα and PITPβ are able to bind to DOPC lipid 
layers (Figures 49 and 50).  In fact, PITPβ demonstrated a higher affinity for membranes 
by nearly two-fold compared to PITPα.   PITPβ’s higher affinity for membranes was also 
reflected by the faster ligand transfer and pick-up rate in comparison to PITPα, as 
discussed in the previous section.  Though the data showed that PITPs do bind to DOPC 
lipid layers, the maximum mass of PITPs bound to this membrane system are relatively 
low compared to other LTPs tested with this method – see Section 3.6.1.  An 
approximate calculation of the theoretical adsorbed mass of PITP to a lipid layer was 
performed assuming 100 % protein coverage – see Tables 6 and 7.  The approximate 
cross section dimension of PITPα from the PDB file 1UW5 is 45 Å.  Thus the specific 
mass of bound protein could be determined as shown in Table 6.   Supposing that PITPα 
had 100 % coverage on the lipid bilayer, the maximum specific mass would be ~2.6 
ng/mm
2
.  However, this was not observed.  Instead, the maximum specific mass was 
determined to be ~0.5 ng/mm
2
.  In reference to Table 7, this represents ~ 19 % protein 
coverage.   
 There are several possible reasons that can explain this lack of protein coverage 
on the immobilized lipid layer.  Either the lipid layer formed is defective or there is 
incomplete lipid coverage on the surface of the sensor chip.  The measured thickness of 
the lipid bilayer formed during DPI analysis has been shown to be 4 – 5 nm, which is 
typical of a membrane bilayer.  Therefore, it is unlikely that the lipid layer formed on the 
sensor chip is defective.  Moreover, the fact that the thickness of the immobilized lipid 
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bilayer is between 4-5 nm means full lipid coverage has been obtained.  Therefore, this 
rules out poor lipid coverage on the sensor chip. 
Table 6: Estimated theoretical adsorbed mass of PITPα to a planar lipid bilayer 
assuming 100 % coverage 
Estimated 
dimension 
(Å) 
Area 
occupied 
(Å
2
) 
Number of 
molecules/mm
2
 
Number of 
moles/mm
2
 
Maximum 
specific 
mass/mm
2
 
(g/mm
2
) 
Maximum 
specific 
mass/mm
2
 
(ng/mm
2
 
45 2025 4.94E+10 8.20E-14 2.61E-09 2.61 
 
Table 7: Estimated protein coverage based on the observed specific mass bound to a 
planar lipid bilayer 
Theoretical observed specific mass 
(ng/mm
2
) 
Calculated protein coverage (%) 
0.1 3.8 
0.2 7.7 
0.3 11.5 
0.4 15.3 
0.5 19.2 
0.6 23.0 
0.7 26.8 
0.8 30.7 
0.9 34.5 
1.0 38.3 
 
 Another possible explanation for the poor protein coverage could be due to the 
way PITPs bind to membranes.  Comparing PITPα and TTP, both proteins have closely 
related Kd values.  But the Bmax value of TTP is nearly four times that of PITPα.  Both 
proteins are about the same molecular weight.  However, both proteins interact with 
membranes differently.  TTP binds to membranes via hydrophobic interactions through 
hydrophobic residues such as phenylalanine, isoleucine, valine, and methionine [95].  
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PITPα on the other hand interacts with membranes through two tryptophan residues 
located side by side [30, 36].  The different membrane binding mechanism may account 
for the difference in protein coverage.  Taking this observation into account and the fact 
that PITPs prefer to bind to curved membrane surfaces as seen with the FRET studies, I 
feel that the DPI methodology may not be an ideal technique for measuring PITP binding 
affinity to membranes.  An alternative method to investigate the binding of PITPs to 
membranes was attempted which involves a tryptophan fluorescence quenching assay.  
This will be discussed in more detail further on.   
 The incorporation of either PI or PS into DOPC lipid layers did not affect PITP 
binding to membranes as revealed through DPI analysis (Figures 51 and 52).  In other 
words, there was no significant increase or decrease in the maximum specific mass of 
PITPs bound to membranes.  This suggests that both PI and PS may not play a role in 
PITP binding to membranes.  These results are in agreement with the FRET transfer 
studies.  In addition, the effect of PE on PITP binding to membranes was also examined 
using DPI.  However, PE did not appear to enhance or detract PITP binding to 
membranes (Figure 53).  The final investigation with DPI involved pre-incubating PITPs 
with either PC or PI and examining the ligand-bound PITP binding to membranes 
(Figure 54).  PC-bound PITPs did not have a higher or lower affinity for DOPC lipid 
layers.  However, PI-bound PITPs showed lower affinity for membranes compared to 
unloaded PITPs.  This is an interesting observation since PITPs has been associated with 
the production of phosphoinositides [34].  In other words, PITPs are believed to play a 
role in supplying PI to membranes for the production of phosphoinositides.  Based on the 
data obtained here, it would seem dysfunctional for PITPs bound to PI to have a lower 
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membrane affinity.  As mentioned in Section 1.4.5, two models have been proposed to 
explain the molecular mechanism of PITPs, which include the PI delivery model and the 
PI presentation model [34].  The lack of membrane affinity with PI-bound PITP clearly 
does not support the former model.  Instead, the data observed here may support the latter 
model.  This could be rationalized as follows: PITP only partially extracts PI, and 
presents the PI to a lipid kinase possibly through protein-protein interactions.  The protein 
must show some affinity for PI, but when artificially loaded with free PI in an in vitro 
incubation the protein is now incapable of recognizing membranes.  However, this notion 
is still preliminary and requires further investigation. 
 When comparing the FRET and DPI studies, it appeared that both techniques 
supported the idea that the ligand-free PITPβ has a higher propensity for binding 
membranes versus PITPα.  The only concern with the DPI results was the low Bmax 
values of PITPs, which was addressed previously.  However, it should be cautioned that 
while the FRET and DPI results are in agreement, PITP binding to membranes and PITP 
ligand delivery are two distinct events.  The ligand transfer rate provided by the FRET 
assays represents a global rate of ligand delivery event as opposed to a specific rate for a 
single mechanistic step – see Figure 57.  When interpreting the FRET data, a faster 
ligand transfer rate may not necessarily mean a higher membrane affinity.   
Since it was presumed that DPI may not be an ideal technique for measuring the 
binding affinity of PITPs to membranes, an alternative method was introduced.  A 
tryptophan fluorescence quenching assay was utilized to measure the affinity of PITPs to 
membranes.  The assay was conducted with and without the presence of a FRET acceptor 
in the lipid vesicles.  Tryptophan has been used as a FRET donor and one common FRET 
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partner of tryptophan is pyrene.  Here, pyrene-PE was used as the FRET acceptor.  Upon 
excitation of tryptophan at 295 nm, if FRET was successful, an increase in the 
fluorescence signal of pyrene-PE would be observed [65].  In both conditions, no 
tryptophan fluorescence quenching was observed.  Neither was there any fluorescence 
increase observed for pyrene-PE when incorporated into the lipid vesicles.  The position 
of pyrene in the pyrene-PE utilized here is located on the head group region of PE.  
Whether the position of pyrene may influence the lack of tryptophan fluorescence 
quenching remains unclear, alternatively, the assay can be tested using pyrene-PE with 
the pyrene group located on the hydrocarbon tail [96].   
 
 
Figure 57: Representation of ligand delivery by PITP 
The ligand transfer rate by PITPs represents a global process as opposed to individual 
kinetic rates; therefore a fast ligand transfer rate may not mean a high membrane affinity 
as both are separate events as shown here. 
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4.3 RdgBα: Lipid Transfer and Membrane Interactions  
 The FRET analysis demonstrated that RdgBα was a poor transporter of NBD-PC 
to membranes (Figure 45).  The RdgBα mutant, Y210A/W211A, showed some transfer 
activity but it was still significantly low compared to wild type PITPα and could be an 
experimental anomaly.  The results obtained here are in agreement with those 
demonstrated by Yadav et al. [76].  As mentioned in Section 3.4.5, the PITP domain in 
RdgBα only shares 40 % sequence similarity with wild type PITPα.  Therefore, it is no 
surprise that its behavior may differ from that of wild type PITPα.  Moreover, RdgBα is a 
multi-domain protein that possesses domains that aids in membrane interactions unlike 
the single domain PITPα.  Therefore, it is possible that the RdgBα’s Y210 and W211 
residues may not be as crucial as the PITPα’s W203 and W204 in membrane docking.   
   DPI studies revealed that both RdgBα and Y210A/W211A were both able to bind 
to DOPC lipid layers (Figure 55).  The maximum specific mass of RdgBα and 
Y210A/W211A at 0.5 μM protein concentration in comparison to PITPα was similar.  
The incorporation of either PI or PS into DOPC lipid layers did not significantly change 
the amount of bound mass of RdgBα.  This is indicative that these lipids do not influence 
RdgBα binding to membranes – a similar trend observed for the PITPs as well.   
4.4 Conclusion 
 In summary, the results obtained from these studies reveal that PITPβ has a higher 
affinity for membranes compared to PITPα.  This was reflected in both DPI 
measurements of binding affinity and FRET assays that measured ligand transfer rates.  
Results from the FRET studies showed that PITPβ has nearly four times faster ligand 
transfer rate than PITPα.  DPI analysis on the other hand revealed a higher affinity for 
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membranes by nearly two-fold compared to PITPα.  This is interesting since both 
proteins are structurally similar.  However, their cellular localization and tissue 
expression differ which implies that both proteins likely serve different functions within 
the cell.   
 Both DPI and FRET studies demonstrated that the presence of PI in membranes 
did not affect the membrane affinity and the ligand transfer rate of PITPs, even though PI 
is the favored ligand of PITPs.  In addition, the role of anionic lipids such as PS also did 
not affect PITP’s membrane interactions and ligand delivery.  However, what was 
interesting was that the presence of PA and phosphoinositides did affect the ligand 
transfer rate of PITPs.  While the presence of PA in membranes enhanced the ligand 
transfer rate of PITPs, the presence of phosphoinositides had the opposite effect.  It is 
understood that PITPs do not bind PA and therefore the increased in ligand transfer rate is 
most likely influenced by physical changes to the membranes brought about by PA, 
which is a negative-inducing curvature lipid [88-90].  While this is true for PA, it is not 
clear whether phosphoinositides have the same effect on PITPs.  Whether PITPs binds 
phosphoinositides directly or recognizes their effect on membrane structure remains to be 
established.  Future studies should establish whether PITPs bind phosphoinositides 
directly.   In addition, the curvature effect brought on by phosphoinositides can be tested 
further by replacing phosphoinositides with lipids with larger head groups such as 
lysophosphatidylcholine.   
 The FRET analysis also revealed that both PITPα and PITPβ showed a propensity 
for highly curved membrane surfaces that now seems to be a common trend with LTPs in 
general.  This observation is meaningful since loosely packed lipid head groups allow 
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easier access for PITPs to bind to membranes and deliver or pick-up its ligand.  While 
DPI was not an ideal technique to examine PITP membrane affinity, a tryptophan 
fluorescence quenching assay using vesicles rather than flat lipid bilayers was employed 
as well.  Unfortunately, this assay was not successful.  The next step would be modifying 
the assay by using pyrene-PE with the pyrene group located on the hydrocarbon tail to 
determine if the location of the pyrene group may be significant here [96].  Alternatively, 
the fluorescence quenching assay can also be conducted using brominated lipids [97].  In 
addition, the use of immobilized vesicles on the DPI could also be a test that can be 
utilized to determine PITP’s membrane binding affinity without the use of planar lipid 
layers [98-99].  Once an alternative method for measuring the membrane affinity of 
PITPs has been established, it would be advantageous to also confirm whether PI-bound 
PITPs have lower affinity for membranes.   
 The FRET studies conducted here mainly involved the use of NBD-PC, which at 
present, is the only commercially available ligand for PITPs.  In future, it would be 
interesting to investigate the ligand transfer rates of PITPs using NBD-PI.   This would be 
particularly useful for the RdgBα protein, which is a poor deliverer of NBD-PC. Since 
our DPI data showed that PI-bound PITPs have lower membrane affinity; I would expect 
to see a lower ligand transfer rate for the PITPs.  However, a higher ligand transfer rate 
for the RdgBα proteins would be expected since their PITP domain may behave 
differently from that of wild type PITPs.   
 In conclusion, the overall results from this study demonstrate the difference in 
membrane interaction behavior between PITPα and PITPβ.  In addition, the data obtained 
here suggests that PITPs, like most LTPs, are recruited to membranes through the 
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recognition of the membranes’ physical parameters such as membrane curvature.  While 
still at its preliminary stage, the outcome of this research project may also help favor the 
PI presentation model over the PI delivery model.   
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6. APPENDIX I  
Nucleotide Sequence of PITPα Mutants Showing Mutated Nucleotides 
Query represents mutant; Sbjct represents wild type PITPα 
W203A/W204A 
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